{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 369123, "items": [{"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T12:03:26Z", "timestamp": 1576670606404}, "reference-count": 44, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 12, 1]], "date-time": "2012-12-01T00:00:00Z", "timestamp": 1354320000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Controlled Release"], "published-print": {"date-parts": [[2012, 12]]}, "DOI": "10.1016/j.jconrel.2012.04.038", "type": "journal-article", "created": {"date-parts": [[2012, 5, 1]], "date-time": "2012-05-01T18:26:48Z", "timestamp": 1335896808000}, "page": "138-144", "source": "Crossref", "is-referenced-by-count": 410, "title": ["Macromolecular therapeutics in cancer treatment: The EPR effect and beyond"], "prefix": "10.1016", "volume": "164", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Controlled Release"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0168365912003197?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0168365912003197?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 23]], "date-time": "2018-11-23T18:53:16Z", "timestamp": 1542999196000}, "score": 53.6164, "issued": {"date-parts": [[2012, 12]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2012, 12]]}, "issue": "2"}, "alternative-id": ["S0168365912003197"], "URL": "http://dx.doi.org/10.1016/j.jconrel.2012.04.038", "ISSN": ["0168-3659"], "issn-type": [{"value": "0168-3659", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T22:03:13Z", "timestamp": 1576879393933}, "reference-count": 55, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 3, 1]], "date-time": "2000-03-01T00:00:00Z", "timestamp": 951868800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Controlled Release"], "published-print": {"date-parts": [[2000, 3]]}, "DOI": "10.1016/s0168-3659(99)00248-5", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T01:36:57Z", "timestamp": 1027647417000}, "page": "271-284", "source": "Crossref", "is-referenced-by-count": 3820, "title": ["Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review"], "prefix": "10.1016", "volume": "65", "author": [{"given": "H", "family": "Maeda", "sequence": "first", "affiliation": []}, {"given": "J", "family": "Wu", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Sawa", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Matsumura", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Hori", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Controlled Release"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0168365999002485?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0168365999002485?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T14:56:34Z", "timestamp": 1555340194000}, "score": 33.017967, "issued": {"date-parts": [[2000, 3]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2000, 3]]}, "issue": "1-2"}, "alternative-id": ["S0168365999002485"], "URL": "http://dx.doi.org/10.1016/s0168-3659(99)00248-5", "ISSN": ["0168-3659"], "issn-type": [{"value": "0168-3659", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T14:39:26Z", "timestamp": 1574174366051}, "publisher-location": "Berlin, Heidelberg", "reference-count": 84, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783540292111", "type": "print"}, {"value": "9783540324492", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 11, 30]], "date-time": "2005-11-30T00:00:00Z", "timestamp": 1133308800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "DOI": "10.1007/12_026", "type": "book-chapter", "created": {"date-parts": [[2005, 12, 16]], "date-time": "2005-12-16T13:08:06Z", "timestamp": 1134738486000}, "page": "103-121", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 99, "title": ["The EPR Effect and Polymeric Drugs: A\u00a0Paradigm Shift for Cancer Chemotherapy in the 21st Century"], "prefix": "10.1007", "author": [{"given": "H.", "family": "Maeda", "sequence": "first", "affiliation": []}, {"given": "K.", "family": "Greish", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Fang", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 11, 30]]}, "reference": [{"key": "26_CR1", "author": "WHO", "year": "2002", "unstructured": "WHO (2002) Press release WHO/52 \u2013 28 June 2002. World Health Organization, Geneva", "volume-title": "Press release WHO/52 \u2013 28 June 2002"}, {"key": "26_CR2", "doi-asserted-by": "publisher", "first-page": "750", "DOI": "10.1038/nrc903", "volume": "2", "author": "TM Allen", "year": "2002", "unstructured": "Allen TM (2002) Nat Rev Cancer 2:750", "journal-title": "Nat Rev Cancer"}, {"key": "26_CR3", "first-page": "6387", "volume": "46", "author": "Y Matsumura", "year": "1986", "unstructured": "Matsumura Y, Maeda H (1986) Cancer Res 46:6387", "journal-title": "Cancer Res"}, {"key": "26_CR4", "first-page": "2115", "volume": "44", "author": "K Iwai", "year": "1984", "unstructured": "Iwai K, Maeda H, Konno T (1984) Cancer Res 44:2115", "journal-title": "Cancer Res"}, {"key": "26_CR5", "first-page": "193", "volume": "6", "author": "H Maeda", "year": "1989", "unstructured": "Maeda H, Matsumura Y (1989) Crit Rev Ther Drug Carrier Syst 6:193", "journal-title": "Crit Rev Ther Drug"}, {"key": "26_CR6", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1111/j.1349-7006.1998.tb00563.x", "volume": "89", "author": "Y Noguchi", "year": "1998", "unstructured": "Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, Maeda H (1998) Jpn J Cancer Res 89:307", "journal-title": "Jpn J Cancer Res"}, {"key": "26_CR7", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1016/S0168-3659(01)00309-1", "volume": "74", "author": "H Maeda", "year": "2001", "unstructured": "Maeda H, Sawa T, Konno T (2001) J Control Release 74:47", "journal-title": "J Control Rel"}, {"key": "26_CR8", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1016/S0065-2571(00)00013-3", "volume": "41", "author": "H Maeda", "year": "2001", "unstructured": "Maeda H (2001) Adv Enzyme Regul 41:189", "journal-title": "Adv Enzyme Regul"}, {"key": "26_CR9", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1016/S1567-5769(02)00271-0", "volume": "3", "author": "H Maeda", "year": "2003", "unstructured": "Maeda H, Fang J, Inutsuka T, Kitamoto Y (2003) Int Immunopharmacol 3:319", "journal-title": "Int Immunopharmacol"}, {"key": "26_CR10", "doi-asserted-by": "publisher", "first-page": "1089", "DOI": "10.2165/00003088-200342130-00002", "volume": "42", "author": "K Greish", "year": "2003", "unstructured": "Greish K, Fang J, Inutsuka T, Nagamitsu A, Maeda H (2003) Clin Pharmacokinet 42:1089", "journal-title": "Clin Pharmacokinet"}, {"key": "26_CR11", "first-page": "16051", "volume": "263", "author": "H Maeda", "year": "1988", "unstructured": "Maeda H, Matsumura Y, Kato H (1988) J Biol Chem 263:16051", "journal-title": "J Biol Chem"}, {"key": "26_CR12", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.1111/j.1349-7006.1988.tb01563.x", "volume": "79", "author": "Y Matsumura", "year": "1988", "unstructured": "Matsumura Y, Kimura M, Yamamoto T, Maeda H (1988) Jpn J Cancer Res 79:1327", "journal-title": "Jpn J Cancer Res"}, {"key": "26_CR13", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1111/j.1349-7006.1991.tb01910.x", "volume": "82", "author": "Y Matsumura", "year": "1991", "unstructured": "Matsumura Y, Maruo K, Kimura M, Yamamoto T, Konno T, Maeda H (1991) Jpn J Cancer Res 82:732", "journal-title": "Jpn J Cancer Res"}, {"key": "26_CR14", "doi-asserted-by": "crossref", "first-page": "1598", "DOI": "10.1002/(SICI)1097-0142(19960415)77:8<1598::AID-CNCR27>3.0.CO;2-U", "volume": "77", "author": "K Doi", "year": "1996", "unstructured": "Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, Ogawa M, Maeda H (1996) Cancer 77:1598", "journal-title": "Cancer"}, {"key": "26_CR15", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1111/j.1349-7006.1994.tb02362.x", "volume": "85", "author": "H Maeda", "year": "1994", "unstructured": "Maeda H, Noguchi Y, Sato K, Akaike T (1994) Jpn J Cancer Res 85:331", "journal-title": "Jpn J Cancer Res"}, {"key": "26_CR16", "first-page": "159", "volume": "58", "author": "J Wu", "year": "1998", "unstructured": "Wu J, Akaike T, Maeda H (1998) Cancer Res 58:159", "journal-title": "Cancer Res"}, {"key": "26_CR17", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/S0162-3109(99)00104-6", "volume": "43", "author": "H Maeda", "year": "1999", "unstructured": "Maeda H, Wu J, Okamoto T, Maruo K, Akaike T (1999) Immunopharmacology 43:115", "journal-title": "Immunopharmacology"}, {"key": "26_CR18", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1111/j.1349-7006.2001.tb01114.x", "volume": "92", "author": "J Wu", "year": "2001", "unstructured": "Wu J, Akaike T, Hayashida K, Okamoto T, Okuyama A, Maeda H (2001) Jpn J Cancer Res 92:439", "journal-title": "Jpn J Cancer Res"}, {"key": "26_CR19", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1002/ijc.10142", "volume": "98", "author": "J Wu", "year": "2002", "unstructured": "Wu J, Akaike T, Hayashida K, Nakagawa T, Miyakawa K, Muller-Esterl W, Maeda H (2002) Int J Cancer\n    98:29", "journal-title": "Int J Cancer"}, {"key": "26_CR20", "doi-asserted-by": "publisher", "first-page": "975", "DOI": "10.1038/bjc.1993.179", "volume": "67", "author": "CJ Li", "year": "1993", "unstructured": "Li CJ, Miyamoto Y, Kojima Y, Maeda H (1993) Br J Cancer 67:975", "journal-title": "Br J Cancer"}, {"key": "26_CR21", "first-page": "663", "volume": "67", "author": "M Suzuki", "year": "1981", "unstructured": "Suzuki M, Hori K, Abe Z, Saito S, Sato H (1981) J Natl Cancer Inst 67:663", "journal-title": "J Natl Cancer Inst"}, {"key": "26_CR22", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1111/j.1349-7006.2000.tb00940.x", "volume": "91", "author": "K Hori", "year": "2000", "unstructured": "Hori K, Saito S, Takahashi H, Sato H, Maeda H, Sato Y (2000) Jpn J Cancer Res 91:261", "journal-title": "Jpn J Cancer Res"}, {"key": "26_CR23", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1080/1061186031000086072", "volume": "1", "author": "S Tanaka", "year": "2003", "unstructured": "Tanaka S, Akaike T, Wu J, Fang J, Sawa T, Ogawa M, Beppu T, Maeda H (2003) J Drug Target 1:45", "journal-title": "J Drug Target"}, {"key": "26_CR24", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1016/j.jconrel.2004.03.027", "volume": "97", "author": "K Greish", "year": "2004", "unstructured": "Greish K, Sawa T, Fang J, Akaike T, Maeda H (2004) J Control Release 97:219", "journal-title": "J Control Rel"}, {"key": "26_CR25", "doi-asserted-by": "publisher", "first-page": "1053", "DOI": "10.1016/0277-5379(83)90028-7", "volume": "19", "author": "T Konno", "year": "1983", "unstructured": "Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, Mochinaga M, Hiraoka T, Yokoyama I (1983)\n    Eur J Cancer Clin Oncol 19:1053", "journal-title": "Eur J Cancer"}, {"key": "26_CR26", "doi-asserted-by": "publisher", "first-page": "2367", "DOI": "10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F", "volume": "54", "author": "T Konno", "year": "1984", "unstructured": "Konno T, Maeda H, Iwai K, Maki S, Tashiro S, Uchida M, Miyauchi Y (1984) Cancer 54:2367", "journal-title": "Cancer"}, {"key": "26_CR27", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1002/1097-0142(19850815)56:4<751::AID-CNCR2820560409>3.0.CO;2-Y", "volume": "56", "author": "S Maki", "year": "1985", "unstructured": "Maki S, Konno T, Maeda H (1985) Cancer 56:751", "journal-title": "Cancer"}, {"key": "26_CR28", "first-page": "321", "volume": "7", "author": "K Iwai", "year": "1987", "unstructured": "Iwai K, Maeda H, Konno T, Matsumura Y, Yamashita R, Yamasaki K, Hirayama S, Miyauchi Y (1987)\n    Anticancer Res 7:321", "journal-title": "Anticancer Res"}, {"key": "26_CR29", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.3109/02841869409098396", "volume": "33", "author": "T Konno", "year": "1994", "unstructured": "Konno T, Kai Y, Yamashita R, Nagamitsu A, Kimura M (1994) Acta Oncol 33:133", "journal-title": "Acta Oncol"}, {"key": "26_CR30", "author": "JW Singer", "first-page": "81", "year": "2003", "unstructured": "Singer JW, Baker B, De P Vries, Kumar A, Shaffer S, Vawter E, Bolton M, Garzone P (2003) In: Maeda\n   H, Kabanov A, Kataoka K, Okano T (eds) Polymer drugs in the clinical stage. Kluwer Academic/Plenum,\n   New York, p 81", "volume-title": "Polymer drugs in the clinical stage"}, {"key": "26_CR31", "doi-asserted-by": "publisher", "first-page": "243", "DOI": "10.1016/S0168-3659(01)00323-6", "volume": "74", "author": "JW Singer", "year": "2001", "unstructured": "Singer JW, Bhatt R, Tulinsky J, Buhler KR, Heasley E, Klein P, de Vries P (2001) J Control Release\n    74:243", "journal-title": "J Control Rel"}, {"key": "26_CR32", "first-page": "666", "volume": "60", "author": "T Sawa", "year": "2000", "unstructured": "Sawa T, Wu J, Akaike T, Maeda H (2000) Cancer Res 60:666", "journal-title": "Cancer Res"}, {"key": "26_CR33", "first-page": "3138", "volume": "62", "author": "J Fang", "year": "2002", "unstructured": "Fang J, Sawa T, Akaike T, Maeda H (2002) Cancer Res 62:3138", "journal-title": "Cancer Res"}, {"key": "26_CR34", "doi-asserted-by": "publisher", "first-page": "1031", "DOI": "10.1021/bc020010k", "volume": "13", "author": "SK Sahoo", "year": "2002", "unstructured": "Sahoo SK, Sawa T, Fang J, Tanaka S, Miyamoto Y, Akaike T, Maeda H (2002) Bioconjug Chem 13:1031", "journal-title": "Bioconjug Chem"}, {"key": "26_CR35", "first-page": "3567", "volume": "63", "author": "J Fang", "year": "2003", "unstructured": "Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Greish K, Hamada A, Maeda H (2003) Cancer Res 63:3567", "journal-title": "Cancer Res"}, {"key": "26_CR36", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/ijc.11644", "volume": "109", "author": "J Fang", "year": "2004", "unstructured": "Fang J, Sawa T, Akaike T, Greish K, Maeda H (2004) Int J Cancer 109:1", "journal-title": "Int J Cancer"}, {"key": "26_CR37", "doi-asserted-by": "publisher", "first-page": "4", "DOI": "10.1093/jnci/82.1.4", "volume": "82", "author": "J Folkman", "year": "1990", "unstructured": "Folkman J (1990) J Natl Cancer Inst 82:4", "journal-title": "J Natl Cancer Inst"}, {"key": "26_CR38", "first-page": "3752", "volume": "55", "author": "F Yuan", "year": "1995", "unstructured": "Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK (1995) Cancer Res 55:3752", "journal-title": "Cancer Res"}, {"key": "26_CR39", "first-page": "2411", "volume": "50", "author": "SA Skinner", "year": "1990", "unstructured": "Skinner SA, Tutton PJ, O'Brien PE (1990) Cancer Res 50:2411", "journal-title": "Cancer Res"}, {"key": "26_CR40", "doi-asserted-by": "publisher", "first-page": "444", "DOI": "10.1002/1097-0142(19870201)59:3<444::AID-CNCR2820590316>3.0.CO;2-5", "volume": "59", "author": "M Suzuki", "year": "1987", "unstructured": "Suzuki M, Takahashi T, Sato T (1987) Cancer 59:444", "journal-title": "Cancer"}, {"key": "26_CR41", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1126/science.6823562", "volume": "219", "author": "DR Senger", "year": "1983", "unstructured": "Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Science 219:983", "journal-title": "Science"}, {"key": "26_CR42", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1038/scientificamerican0794-58", "volume": "271", "author": "R Jain", "year": "1994", "unstructured": "Jain R (1994) Sci Am 271:58", "journal-title": "Sci Am"}, {"key": "26_CR43", "first-page": "149", "volume": "9", "author": "R Duncan", "year": "1998", "unstructured": "Duncan R, Sat YN (1998) Ann Oncol 9:149", "journal-title": "Ann Oncol"}, {"key": "26_CR44", "doi-asserted-by": "publisher", "first-page": "441", "DOI": "10.1016/S1461-5347(99)00211-4", "volume": "2", "author": "R Duncan", "year": "1999", "unstructured": "Duncan R (1999) Pharm Sci Technol Today 2:441", "journal-title": "Pharm Sci Technol Today"}, {"key": "26_CR45", "doi-asserted-by": "publisher", "first-page": "766", "DOI": "10.1016/0959-8049(94)00514-6", "volume": "31", "author": "LW Seymour", "year": "1995", "unstructured": "Seymour LW, Miyamoto Y, Maeda H, Brereton M, Strohalm J, Ulbrich K, Duncan R (1995) Eur J Cancer\n   31:766", "journal-title": "Eur J Cancer"}, {"key": "26_CR46", "doi-asserted-by": "publisher", "first-page": "1363", "DOI": "10.1016/S0002-9440(10)65006-7", "volume": "156", "author": "H Hashizume", "year": "2000", "unstructured": "Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM (2000)\n    Am J Pathol 156:1363", "journal-title": "Am J Pathol"}, {"key": "26_CR47", "first-page": "1640", "volume": "50", "author": "K Ohkouchi", "year": "1990", "unstructured": "Ohkouchi K, Imoto H, Takakura Y, Hashida M, Sezaki H (1990) Cancer Res 50:1640", "journal-title": "Cancer Res"}, {"key": "26_CR48", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1007/BF01040499", "volume": "3", "author": "H Maeda", "year": "1984", "unstructured": "Maeda H, Matsumoto T, Konno T (1984) J Protein Chem 3:181", "journal-title": "J Protein Chem"}, {"key": "26_CR49", "doi-asserted-by": "publisher", "first-page": "1103", "DOI": "10.1515/BC.2000.135", "volume": "11", "author": "J Plendl", "year": "2000", "unstructured": "Plendl J, Snyman C, Naidoo S, Sawant S, Mahabeer R, Bhoola KD (2000) Biol Chem 11:1103", "journal-title": "Biol Chem"}, {"key": "26_CR50", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1002/ijc.2910150503", "volume": "15", "author": "HR Strausser", "year": "1975", "unstructured": "Strausser HR, Humes JL (1975) Int J Cancer 15:724", "journal-title": "Int J Cancer"}, {"key": "26_CR51", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1038/bjc.1980.56", "volume": "41", "author": "A Trevisani", "year": "1980", "unstructured": "Trevisani A, Ferretti E, Capuzzo A, Tomasi V (1980) Br J Cancer 41:341", "journal-title": "Br J Cancer"}, {"key": "26_CR52", "doi-asserted-by": "publisher", "first-page": "1169", "DOI": "10.1038/bjc.1995.228", "volume": "71", "author": "RE Meyer", "year": "1995", "unstructured": "Meyer RE, Shan S, Dan J, Dodge RK, Bonaventura J, Ong ET, Dewhirst MW (1995) Br J Cancer 71:1169", "journal-title": "Br J Cancer"}, {"key": "26_CR53", "first-page": "948", "volume": "57", "author": "GM Tozer", "year": "1997", "unstructured": "Tozer GM, Prise VE, Chaplin DJ (1997) Cancer Res 57:948", "journal-title": "Cancer Res"}, {"key": "26_CR54", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1093/jnci/90.8.587", "volume": "90", "author": "O Gallo", "year": "1998", "unstructured": "Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, Ziche M (1998) J Natl\n   Cancer Inst 90:587", "journal-title": "J Natl Cancer Inst"}, {"key": "26_CR55", "doi-asserted-by": "publisher", "first-page": "560", "DOI": "10.1093/jnci/90.8.560", "volume": "90", "author": "G Garcia-Cardena", "year": "1998", "unstructured": "Garcia-Cardena G, Folkman J (1998) J Natl Cancer Inst 90:560", "journal-title": "J Natl Cancer Inst"}, {"key": "26_CR56", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1096/fasebj.11.6.9194526", "volume": "11", "author": "JR Jackson", "year": "1997", "unstructured": "Jackson JR, Seed MP, Kirchen CH, Willoughby DA, Wannan JD (1997) FASEB J 11:457", "journal-title": "FASEB J"}, {"key": "26_CR57", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1006/abbi.1997.0127", "volume": "342", "author": "T Okamoto", "year": "1997", "unstructured": "Okamoto T, Akaike T, Nagano T, Miyajima S, Suga M, Ando M, Ichimori K, Maeda H (1997) Arch Biochem\n    Biophys 342:26", "journal-title": "Arch Biochem Biophys"}, {"key": "26_CR58", "first-page": "554", "volume": "35", "author": "H Maeda", "year": "1975", "unstructured": "Maeda H, Aikawa S, Yamashita A (1975) Cancer Res 35:554", "journal-title": "Cancer Res"}, {"key": "26_CR59", "first-page": "3206", "volume": "47", "author": "T Oda", "year": "1987", "unstructured": "Oda T, Maeda H (1987) Cancer Res 47:3206", "journal-title": "Cancer Res"}, {"key": "26_CR60", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/S0168-3659(01)00328-5", "volume": "74", "author": "R Duncan", "year": "2001", "unstructured": "Duncan R, Gac-Breton S, Keane R, Musila R, Sat YN, Satchi R, Searle F (2001) J Control Release\n   74:135", "journal-title": "J Control Rel"}, {"key": "26_CR61", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1091/mbc.01-06-0280", "volume": "13", "author": "P Pellegrin", "year": "2002", "unstructured": "Pellegrin P, Fernandez A, Lamb NJ, Bennes R (2002) Mol Biol Cell 13:570", "journal-title": "Mol Biol Cell"}, {"key": "26_CR62", "first-page": "1571", "volume": "50", "author": "Y Miyamoto", "year": "1990", "unstructured": "Miyamoto Y, Oda T, Maeda H (1990) Cancer Res 50:1571", "journal-title": "Cancer Res"}, {"key": "26_CR63", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1016/S0959-8049(98)00373-6", "volume": "35", "author": "M St'astny", "year": "1990", "unstructured": "St'astny M, Strohalm J, Plocova D, Ulbrich K, Rihova B (1990) Eur J Cancer 35:459", "journal-title": "Eur J Cancer"}, {"key": "26_CR64", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1016/S0168-3659(98)00009-1", "volume": "54", "author": "T Minko", "year": "1998", "unstructured": "Minko T, Kopeckova P, Pozharov V, Kopecek J (1998) J Control Release 54:223", "journal-title": "J Control Rel"}, {"key": "26_CR65", "first-page": "175", "volume": "1", "author": "H Maeda", "year": "1981", "unstructured": "Maeda H (1981) Anticancer Res 1:175", "journal-title": "Anticancer Res"}, {"key": "26_CR66", "author": "H Maeda", "first-page": "23", "year": "1997", "unstructured": "Maeda H (1997) In: Maeda H, Edo K, Ishida N (eds) Neocarzinostatin: The past, present, and future\n   of an anticancer drug. Springer, Berlin Heidelberg New York, p 23", "volume-title": "Neocarzinostatin: The past, present, and future of an anticancer drug", "DOI": "10.1007/978-4-431-66914-2", "doi-asserted-by": "crossref"}, {"key": "26_CR67", "author": "K Ohtsuki", "first-page": "129", "year": "1997", "unstructured": "Ohtsuki K, Ono Y (1997) In: Maeda H, Edo K, Ishida N (eds) Neocarzinostatin: The past, present,\n    and future of an anticancer drug. Springer, Berlin Heidelberg New York, p 129", "volume-title": "Neocarzinostatin: The past, present, and future of an anticancer drug", "DOI": "10.1007/978-4-431-66914-2_7", "doi-asserted-by": "crossref"}, {"key": "26_CR68", "doi-asserted-by": "publisher", "first-page": "1716", "DOI": "10.1006/bbrc.1994.2866", "volume": "205", "author": "K Sato", "year": "1994", "unstructured": "Sato K, Akaike T, Suga M, Ando M, Maeda H (1994) Biochem Biophys Res Commun 205:1716", "journal-title": "Biochem Biophys Res Commun"}, {"key": "26_CR69", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/0169-409X(91)90040-J", "volume": "6", "author": "H Maeda", "year": "1991", "unstructured": "Maeda H (1991) Adv Drug Deliv Rev 6:181", "journal-title": "Adv Drug Deliv Rev"}, {"key": "26_CR70", "first-page": "1217", "volume": "12", "author": "LW Seymour", "year": "1998", "unstructured": "Seymour LW, Olliff SP, Poole CJ, De Takats PG, Orme R, Ferry DR, Maeda H, Konno T, Kerr DJ (1998)\n   Int J Oncol 12:1217", "journal-title": "Int J Oncol"}, {"key": "26_CR71", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1007/PL00009972", "volume": "35", "author": "S Abe", "year": "2000", "unstructured": "Abe S, Okubo Y, Ejiri Y, Kume K, Otsuki M (2000) J Gastroenterol 35:28", "journal-title": "J Gastroenterol"}, {"key": "26_CR72", "doi-asserted-by": "publisher", "first-page": "276", "DOI": "10.1159/000011863", "volume": "55", "author": "T Okusaka", "year": "1998", "unstructured": "Okusaka T, Okada S, Ishii H, Ikeda M, Nakasuka H, Nagahama H, Iwata R, Furukawa H, Takayasu K,\n    Nakanishi Y, Sakamoto M, Hirohashi S, Yoshimori M (1998) Oncology 55:276", "journal-title": "Oncology"}, {"key": "26_CR73", "doi-asserted-by": "publisher", "first-page": "228", "DOI": "10.1159/000059570", "volume": "62", "author": "T Okusaka", "year": "2002", "unstructured": "Okusaka T, Okada S, Ueno H, Ikeda M, Iwata R, Furukawa H, Takayasu K, Moriyama N, Sato T, Sato\n   K (2002) Oncology 62:228", "journal-title": "Oncology"}, {"key": "26_CR74", "author": "JP Greenstein", "year": "1954", "unstructured": "Greenstein JP (1954) Biochemistry of cancer, 2nd edn. Academic, New York", "volume-title": "Biochemistry of cancer, 2nd edn"}, {"key": "26_CR75", "first-page": "95", "volume": "6", "author": "NY Amanaka", "year": "1974", "unstructured": "Amanaka NY, Deamer D (1974) Physiol Chem Phys 6:95", "journal-title": "Physiol Chem Phys"}, {"key": "26_CR76", "doi-asserted-by": "crossref", "first-page": "2525", "DOI": "10.1128/MCB.12.6.2525", "volume": "12", "author": "K Sato", "year": "1992", "unstructured": "Sato K, Ito K, Kohara H, Yamaguchi Y, Adachi K, Endo H (1992) Mol Cell Biol 12:2525", "journal-title": "Mol Cell Biol"}, {"key": "26_CR77", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1016/S0090-4295(96)00010-6", "volume": "47", "author": "MD Maines", "year": "1996", "unstructured": "Maines MD, Abrahamsson PA (1996) Urology 47:727", "journal-title": "Urology"}, {"key": "26_CR78", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.3181/00379727-214-44069", "volume": "214", "author": "AI Goodman", "year": "1997", "unstructured": "Goodman AI, Choudhury M, da Silva JL, Schwartzman ML, Abraham NG (1997) Proc Soc Exp Biol Med\n   214:54", "journal-title": "Proc Soc Exp Biol Med"}, {"key": "26_CR79", "doi-asserted-by": "publisher", "first-page": "1954", "DOI": "10.1038/sj.bjc.6690624", "volume": "80", "author": "K Doi", "year": "1999", "unstructured": "Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, Maeda H (1999) Br\n   J Cancer 80:1954", "journal-title": "Br J Cancer"}, {"key": "26_CR80", "first-page": "69", "volume": "182", "author": "Y Hasegawa", "year": "2002", "unstructured": "Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N (2002) Cancer Lett 182:69", "journal-title": "Cancer"}, {"key": "26_CR81", "doi-asserted-by": "publisher", "first-page": "902", "DOI": "10.1038/sj.bjc.6600830", "volume": "82", "author": "S Tanaka", "year": "2003", "unstructured": "Tanaka S, Akaike T, Fang J, Beppu T, Ogawa M, Tamura F, Miyamoto Y, Maeda H (2003) Br J Cancer\n         82:902", "journal-title": "Br J Cancer"}, {"key": "26_CR82", "first-page": "349", "volume": "25", "author": "BA Schacter", "year": "1988", "unstructured": "Schacter BA (1988) Semin Hematol 25:349", "journal-title": "Semin Hematol"}, {"key": "26_CR83", "doi-asserted-by": "crossref", "first-page": "2557", "DOI": "10.1096/fasebj.2.10.3290025", "volume": "2", "author": "MD Maines", "year": "1988", "unstructured": "Maines MD (1988) FASEB J 2:2557", "journal-title": "FASEB J"}, {"key": "26_CR84", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1006/abbi.1998.0584", "volume": "352", "author": "M Minetti", "year": "1998", "unstructured": "Minetti M, Mallozzi C, DiStasi AM, Pietraforte D (1998) Arch Biochem Biophys 352:165", "journal-title": "Arch Biochem Biophys"}], "container-title": ["Polymer Therapeutics II", "Advances in Polymer Science"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/12_026", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 21]], "date-time": "2019-05-21T19:13:35Z", "timestamp": 1558466015000}, "score": 31.60822, "issued": {"date-parts": [[2005, 11, 30]]}, "ISBN": ["9783540292111", "9783540324492"], "references-count": 84, "URL": "http://dx.doi.org/10.1007/12_026", "relation": {"cites": []}, "ISSN": ["0065-3195"], "issn-type": [{"value": "0065-3195", "type": "print"}], "assertion": [{"value": "30 November 2005", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ChapterHistory", "label": "Chapter History"}}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T08:49:44Z", "timestamp": 1574844584100}, "reference-count": 41, "publisher": "Informa UK Limited", "issue": "9-10", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Drug Targeting"], "published-print": {"date-parts": [[2017, 11, 26]]}, "DOI": "10.1080/1061186x.2017.1365878", "type": "journal-article", "created": {"date-parts": [[2017, 10, 9]], "date-time": "2017-10-09T08:27:37Z", "timestamp": 1507537657000}, "page": "781-785", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Polymer therapeutics and the EPR effect"], "prefix": "10.1080", "volume": "25", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": [{"name": "Kumamoto University and BioDynamic Research Foundation, Kumamoto, Japan;"}, {"name": "Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan"}]}], "member": "301", "published-online": {"date-parts": [[2017, 10, 9]]}, "reference": [{"key": "CIT0001", "DOI": "10.1126/science.2543070", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1111/j.1399-3011.1979.tb01730.x", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1016/0304-4165(79)90450-1", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1002/macp.1983.021841005", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1038/bjc.1988.31", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1016/0006-2952(89)90274-8", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1016/0304-4165(86)90120-0", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "author": "Vasey PA", "volume": "5", "first-page": "83", "year": "1999", "journal-title": "Clin Cancer Res"}, {"key": "CIT0009", "DOI": "10.1016/S0168-3659(98)00124-2", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.3892/ijo_00000293", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1177/088391158600100103", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1016/0142-9612(89)90075-6", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1038/bjc.1994.363", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "author": "Matsumura Y", "volume": "46", "first-page": "6387", "year": "1986", "journal-title": "Cancer Res"}, {"key": "CIT0015", "author": "Maeda H", "volume": "6", "first-page": "193", "year": "1989", "journal-title": "Crit Rev Ther Drug Carrier Syst"}, {"key": "CIT0016", "DOI": "10.1016/0169-409X(91)90040-J", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1016/j.addr.2015.01.002", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1111/j.1349-7006.1998.tb00563.x", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1016/0959-8049(94)00514-6", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1016/S0168-3659(99)00248-5", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.1093/jjco/hyp074", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.2183/pjab.88.53", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1517/17425247.2014.955011", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1007/s11523-015-0379-4", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.1093/oxfordjournals.jbchem.a134892", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.1016/S0161-6420(85)33855-1", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "author": "Maeda H", "volume": "377", "first-page": "217", "year": "1996", "journal-title": "Biological Chem Hoppe-Seyler"}, {"key": "CIT0028", "DOI": "10.1016/0014-2964(80)90215-7", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "author": "Maeda H", "volume": "70", "first-page": "601", "year": "1979", "journal-title": "Gann"}, {"key": "CIT0030", "author": "Takeshita J", "volume": "73", "first-page": "278", "year": "1982", "journal-title": "Gann"}, {"key": "CIT0031", "DOI": "10.1111/micc.12228", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "DOI": "10.1111/j.1349-7006.1994.tb02362.x", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1016/0162-3109(96)00063-X", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "author": "Wu J", "volume": "58", "first-page": "159", "year": "1998", "journal-title": "Cancer Res"}, {"key": "CIT0035", "DOI": "10.1111/cas.12152", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1111/j.1349-7006.2009.01323.x", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.1016/j.addr.2012.10.002", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "DOI": "10.1002/1097-0142(19870501)59:9<1560::AID-CNCR2820590905>3.0.CO;2-J", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "author": "Yamasaki K", "volume": "47", "first-page": "852", "year": "1987", "journal-title": "Cancer Res"}, {"key": "CIT0040", "author": "Oda T", "volume": "47", "first-page": "3206", "year": "1987", "journal-title": "Cancer Res"}, {"key": "CIT0041", "DOI": "10.1016/j.jconrel.2012.04.038", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Drug Targeting"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2017.1365878", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T13:20:26Z", "timestamp": 1553174426000}, "score": 30.328327, "issued": {"date-parts": [[2017, 10, 9]]}, "references-count": 41, "journal-issue": {"published-online": {"date-parts": [[2017, 9, 21]]}, "published-print": {"date-parts": [[2017, 11, 26]]}, "issue": "9-10"}, "alternative-id": ["10.1080/1061186X.2017.1365878"], "URL": "http://dx.doi.org/10.1080/1061186x.2017.1365878", "relation": {"cites": []}, "ISSN": ["1061-186X", "1029-2330"], "issn-type": [{"value": "1061-186X", "type": "print"}, {"value": "1029-2330", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=idrt20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=idrt20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}, {"value": "2017-08-05", "order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2017-08-08", "order": 1, "name": "revised", "label": "Revised", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2017-08-07", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2017-10-09", "order": 3, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T16:04:04Z", "timestamp": 1576857844261}, "reference-count": 59, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 5, 1]], "date-time": "2001-05-01T00:00:00Z", "timestamp": 988675200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advances in Enzyme Regulation"], "published-print": {"date-parts": [[2001, 5]]}, "DOI": "10.1016/s0065-2571(00)00013-3", "type": "journal-article", "created": {"date-parts": [[2003, 2, 17]], "date-time": "2003-02-17T17:19:30Z", "timestamp": 1045502370000}, "page": "189-207", "source": "Crossref", "is-referenced-by-count": 1447, "title": ["The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting"], "prefix": "10.1016", "volume": "41", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Advances in Enzyme Regulation"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0065257100000133?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0065257100000133?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T16:24:22Z", "timestamp": 1555691062000}, "score": 28.16589, "issued": {"date-parts": [[2001, 5]]}, "references-count": 59, "journal-issue": {"published-print": {"date-parts": [[2001, 5]]}, "issue": "1"}, "alternative-id": ["S0065257100000133"], "URL": "http://dx.doi.org/10.1016/s0065-2571(00)00013-3", "ISSN": ["0065-2571"], "issn-type": [{"value": "0065-2571", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T15:27:03Z", "timestamp": 1576855623863}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Bioconjugate Chem."], "published-print": {"date-parts": [[2010, 5, 19]]}, "DOI": "10.1021/bc100070g", "type": "journal-article", "created": {"date-parts": [[2010, 4, 16]], "date-time": "2010-04-16T17:22:32Z", "timestamp": 1271438552000}, "page": "797-802", "source": "Crossref", "is-referenced-by-count": 585, "title": ["Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects"], "prefix": "10.1021", "volume": "21", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}], "member": "316", "container-title": ["Bioconjugate Chemistry"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/bc100070g", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 28]], "date-time": "2019-09-28T01:24:14Z", "timestamp": 1569633854000}, "score": 28.16589, "issued": {"date-parts": [[2010, 5, 19]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 5, 19]]}, "issue": "5"}, "alternative-id": ["10.1021/bc100070g"], "URL": "http://dx.doi.org/10.1021/bc100070g", "ISSN": ["1043-1802", "1520-4812"], "issn-type": [{"value": "1043-1802", "type": "print"}, {"value": "1520-4812", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 21]], "date-time": "2019-12-21T09:43:17Z", "timestamp": 1576921397808}, "reference-count": 116, "publisher": "Wiley", "issue": "7", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 862, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Sci"], "published-print": {"date-parts": [[2013, 7]]}, "DOI": "10.1111/cas.12152", "type": "journal-article", "created": {"date-parts": [[2013, 3, 17]], "date-time": "2013-03-17T02:15:56Z", "timestamp": 1363486556000}, "page": "779-789", "source": "Crossref", "is-referenced-by-count": 73, "title": ["The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect"], "prefix": "10.1111", "volume": "104", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": [{"name": "Institute of Drug Delivery System Research; Sojo University; Kumamoto; Japan"}]}], "member": "311", "published-online": {"date-parts": [[2013, 4, 22]]}, "reference": [{"key": "10.1111/cas.12152-BIB0001|cas12152-cit-0001", "author": "Maeda", "first-page": "227", "year": "1997", "volume-title": "Neocarzinostatin: The Past, Present, and Future of an Anticancer Drug", "DOI": "10.1007/978-4-431-66914-2_12", "doi-asserted-by": "crossref"}, {"key": "10.1111/cas.12152-BIB0002|cas12152-cit-0002", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1111/j.1399-3011.1979.tb01730.x", "article-title": "A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic", "volume": "14", "author": "Maeda", "year": "1979", "journal-title": "Int J Pept Protein Res"}, {"key": "10.1111/cas.12152-BIB0003|cas12152-cit-0003", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1021/jm00382a012", "article-title": "Conjugation of poly (styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties", "volume": "28", "author": "Maeda", "year": "1985", "journal-title": "J Med Chem"}, {"key": "10.1111/cas.12152-BIB0004|cas12152-cit-0004", "first-page": "601", "article-title": "Antimetastatic and antitumor activity of a derivative of neocarzinostatin: an organic solvent- and water-soluble polymer-conjugated protein", "volume": "70", "author": "Maeda", "year": "1979", "journal-title": "Gann"}, {"key": "10.1111/cas.12152-BIB0005|cas12152-cit-0005", "first-page": "6387", "article-title": "A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs", "volume": "46", "author": "Matsumura", "year": "1986", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0006|cas12152-cit-0006", "first-page": "193", "article-title": "Tumoritropic and lymphotropic principles of macromolecular drugs", "volume": "6", "author": "Maeda", "year": "1989", "journal-title": "Crit Rev Ther Drug Carrier Syst"}, {"key": "10.1111/cas.12152-BIB0007|cas12152-cit-0007", "first-page": "278", "article-title": "In vitro mode of action, pharmacokinetics, and organ specificity of poly(maleic acid-styrene)-conjugated neocarzinostatin, SMANCS", "volume": "73", "author": "Takeshita", "year": "1982", "journal-title": "Gann"}, {"key": "10.1111/cas.12152-BIB0008|cas12152-cit-0008", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1007/BF01040499", "article-title": "Tailor-making of protein drugs by polymer conjugation for tumor targeting: a brief review on Smancs", "volume": "3", "author": "Maeda", "year": "1984", "journal-title": "J Protein Chem"}, {"key": "10.1111/cas.12152-BIB0009|cas12152-cit-0009", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1177/088391158800300401", "article-title": "Protein binding of macromolecular anticancer agent SMANCS: characterization of poly(styrene-co-maleic acid) derivatives as an albumin binding ligand", "volume": "3", "author": "Kobayashi", "year": "1988", "journal-title": "J Bioact Compat Polym"}, {"key": "10.1111/cas.12152-BIB0010|cas12152-cit-0010", "doi-asserted-by": "crossref", "first-page": "852", "DOI": "10.1023/A:1015917000556", "article-title": "Enhanced intestinal absorption of a hydrophobic polymer-conjugated protein drug, smancs, in an oily formulation", "volume": "7", "author": "Oka", "year": "1990", "journal-title": "Pharmaceut Res"}, {"key": "10.1111/cas.12152-BIB0011|cas12152-cit-0011", "first-page": "1571", "article-title": "Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro", "volume": "50", "author": "Miyamoto", "year": "1990", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0012|cas12152-cit-0012", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1111/j.1349-7006.1998.tb00563.x", "article-title": "Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues", "volume": "89", "author": "Noguchi", "year": "1998", "journal-title": "Jpn J Cancer Res"}, {"key": "10.1111/cas.12152-BIB0013|cas12152-cit-0013", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1016/0959-8049(94)00514-6", "article-title": "Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier", "volume": "31", "author": "Seymour", "year": "1995", "journal-title": "Eur J Cancer"}, {"key": "10.1111/cas.12152-BIB0014|cas12152-cit-0014", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1021/bc00017a001", "article-title": "Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo", "volume": "3", "author": "Maeda", "year": "1992", "journal-title": "Bioconj Chem"}, {"key": "10.1111/cas.12152-BIB0015|cas12152-cit-0015", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1016/S0168-3659(99)00248-5", "article-title": "Tumor vascular permeability and the EPR effect in macromolecular therapeutics", "volume": "65", "author": "Maeda", "year": "2000", "journal-title": "J Control Release"}, {"key": "10.1111/cas.12152-BIB0016|cas12152-cit-0016", "first-page": "16051", "article-title": "Purification and identification of [hydroxprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer", "volume": "263", "author": "Maeda", "year": "1988", "journal-title": "J Biol Chem"}, {"key": "10.1111/cas.12152-BIB0017|cas12152-cit-0017", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1111/j.1349-7006.1994.tb02362.x", "article-title": "Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor", "volume": "85", "author": "Maeda", "year": "1994", "journal-title": "Jpn J Cancer Res"}, {"key": "10.1111/cas.12152-BIB0018|cas12152-cit-0018", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/S0162-3109(99)00104-6", "article-title": "Kallikrein-kinin in infection and cancer", "volume": "43", "author": "Maeda", "year": "1999", "journal-title": "Immunopharmacology"}, {"key": "10.1111/cas.12152-BIB0019|cas12152-cit-0019", "first-page": "159", "article-title": "Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger", "volume": "58", "author": "Wu", "year": "1998", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0020|cas12152-cit-0020", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1111/j.1349-7006.2001.tb01114.x", "article-title": "Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinase", "volume": "92", "author": "Wu", "year": "2001", "journal-title": "Jpn J Cancer Res"}, {"key": "10.1111/cas.12152-BIB0021|cas12152-cit-0021", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1016/S0065-2571(00)00013-3", "article-title": "The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting", "volume": "41", "author": "Maeda", "year": "2001", "journal-title": "Adv Enzyme Regul"}, {"key": "10.1111/cas.12152-BIB0022|cas12152-cit-0022", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/S0168-3659(01)00309-1", "article-title": "Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS", "volume": "74", "author": "Maeda", "year": "2001", "journal-title": "J Cont Release"}, {"key": "10.1111/cas.12152-BIB0023|cas12152-cit-0023", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1111/j.1574-6968.1993.tb06559.x", "article-title": "Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs", "volume": "114", "author": "Kaminishi", "year": "1993", "journal-title": "FEMS Microbiol Lett"}, {"key": "10.1111/cas.12152-BIB0024|cas12152-cit-0024", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1111/j.1574-6968.1994.tb07121.x", "article-title": "Activation of blood clotting factors by microbial proteinases", "volume": "121", "author": "Kaminishi", "year": "1994", "journal-title": "FEMS Microbiol Lett"}, {"key": "10.1111/cas.12152-BIB0025|cas12152-cit-0025", "first-page": "984", "article-title": "Degradation of humoral host defense by Candida albicans proteinase", "volume": "63", "author": "Kaminishi", "year": "1995", "journal-title": "Infect Immun"}, {"key": "10.1111/cas.12152-BIB0026|cas12152-cit-0026", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1093/oxfordjournals.jbchem.a134892", "article-title": "Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease", "volume": "96", "author": "Matsumoto", "year": "1984", "journal-title": "J Biochem"}, {"key": "10.1111/cas.12152-BIB0027|cas12152-cit-0027", "first-page": "747", "article-title": "A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs", "volume": "48", "author": "Kamata", "year": "1985", "journal-title": "Infect Immun"}, {"key": "10.1111/cas.12152-BIB0028|cas12152-cit-0028", "first-page": "10589", "article-title": "Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases", "volume": "264", "author": "Molla", "year": "1989", "journal-title": "J Biol Chem"}, {"key": "10.1111/cas.12152-BIB0029|cas12152-cit-0029", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1111/j.1348-0421.1996.tb01129.x", "article-title": "Role of microbial proteases in pathogenesis", "volume": "40", "author": "Maeda", "year": "1996", "journal-title": "Microbiol Immunol"}, {"key": "10.1111/cas.12152-BIB0030|cas12152-cit-0030", "author": "Maeda", "volume": "4", "first-page": "2663", "year": "2002", "volume-title": "Wiley Encyclopedia of Molecular Medicine"}, {"key": "10.1111/cas.12152-BIB0031|cas12152-cit-0031", "first-page": "17711", "article-title": "Effect of microbial and mite proteases on low and high molecular weight kininogens", "volume": "268", "author": "Maruo", "year": "1993", "journal-title": "J Biol Chem"}, {"key": "10.1111/cas.12152-BIB0032|cas12152-cit-0032", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.1111/j.1349-7006.1988.tb01563.x", "article-title": "Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue", "volume": "79", "author": "Matsumura", "year": "1988", "journal-title": "Jpn J Cancer Res"}, {"key": "10.1111/cas.12152-BIB0033|cas12152-cit-0033", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1111/j.1349-7006.1991.tb01910.x", "article-title": "Kinin-generating cascade in advanced cancer patients and in vitro study", "volume": "82", "author": "Matsumura", "year": "1991", "journal-title": "Jpn J Cancer Res"}, {"key": "10.1111/cas.12152-BIB0034|cas12152-cit-0034", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1007/978-1-4615-9543-4_91", "article-title": "Quantification, isolation and structural determination of bradykinin and hydroxyprolyl-bradykinin in tumor ascites", "volume": "247A", "author": "Matsumura", "year": "1989", "journal-title": "Adv Exp Med Biol"}, {"key": "10.1111/cas.12152-BIB0035|cas12152-cit-0035", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1515/BC.2001.013", "article-title": "Kallikrein and kinin receptor expression in inflammation and cancer", "volume": "382", "author": "Bhoola", "year": "2001", "journal-title": "Biol Chem"}, {"key": "10.1111/cas.12152-BIB0036|cas12152-cit-0036", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1002/ijc.10142", "article-title": "Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues", "volume": "98", "author": "Wu", "year": "2002", "journal-title": "Int J Cancer"}, {"key": "10.1111/cas.12152-BIB0037|cas12152-cit-0037", "doi-asserted-by": "crossref", "first-page": "1129", "DOI": "10.1517/17460441.2012.729038", "article-title": "Discovery and therapeutic potential of kinin receptor antagonists", "volume": "7", "author": "Whalley", "year": "2012", "journal-title": "Expert Opin Drug Discov"}, {"key": "10.1111/cas.12152-BIB0038|cas12152-cit-0038", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1517/14728222.2012.662957", "article-title": "Kinin receptors as targets for cancer therapy", "volume": "16", "author": "Figueroa", "year": "2012", "journal-title": "Expert Opin Ther Targets"}, {"key": "10.1111/cas.12152-BIB0039|cas12152-cit-0039", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1126/science.2543070", "article-title": "Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD", "volume": "244", "author": "Oda", "year": "1989", "journal-title": "Science"}, {"key": "10.1111/cas.12152-BIB0040|cas12152-cit-0040", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1172/JCI114499", "article-title": "Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice", "volume": "85", "author": "Akaike", "year": "1990", "journal-title": "J Clin Invest"}, {"key": "10.1111/cas.12152-BIB0041|cas12152-cit-0041", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.3181/00379727-198-43309C", "article-title": "Oxygen free radicals as pathogenic molecules in viral diseases", "volume": "198", "author": "Maeda", "year": "1991", "journal-title": "Proc Soc Exp Biol Med"}, {"key": "10.1111/cas.12152-BIB0042|cas12152-cit-0042", "unstructured": "Maeda H Paradigm shift in microbial pathogenesis: an alternative to the Koch-Pasteur paradigm on the new millennium Arai S"}, {"key": "10.1111/cas.12152-BIB0043|cas12152-cit-0043", "doi-asserted-by": "crossref", "first-page": "2448", "DOI": "10.1073/pnas.93.6.2448", "article-title": "Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals", "volume": "93", "author": "Akaike", "year": "1996", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/cas.12152-BIB0044|cas12152-cit-0044", "doi-asserted-by": "crossref", "first-page": "8709", "DOI": "10.1128/JVI.78.16.8709-8719.2004", "article-title": "Nitric oxide as an endogenous mutagen for Sendai virus without antiviral activity", "volume": "78", "author": "Yoshitake", "year": "2004", "journal-title": "J Virol"}, {"key": "10.1111/cas.12152-BIB0045|cas12152-cit-0045", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1046/j.1365-2567.2000.00142.x", "article-title": "Nitric oxide and virus infection", "volume": "101", "author": "Akaike", "year": "2000", "journal-title": "Immunology"}, {"key": "10.1111/cas.12152-BIB0046|cas12152-cit-0046", "author": "Akaike", "first-page": "733", "year": "2000", "volume-title": "Nitric Oxide", "DOI": "10.1016/B978-012370420-7/50047-2", "doi-asserted-by": "crossref"}, {"key": "10.1111/cas.12152-BIB0047|cas12152-cit-0047", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1073/pnas.0235623100", "article-title": "8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis", "volume": "100", "author": "Akaike", "year": "2003", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/cas.12152-BIB0048|cas12152-cit-0048", "doi-asserted-by": "crossref", "first-page": "1447", "DOI": "10.1096/fj.14.10.1447", "article-title": "Viral mutation accelerated by nitric oxide production during infection in vivo", "volume": "14", "author": "Akaike", "year": "2000", "journal-title": "FASEB J"}, {"key": "10.1111/cas.12152-BIB0049|cas12152-cit-0049", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1348-0421.2008.00089.x", "article-title": "Generation of drug-resistant mutants of Helicobacter pylori in the presence of peroxynitrite, a derivative of nitric oxide, at pathophysiological concentration", "volume": "52", "author": "Kuwahara", "year": "2009", "journal-title": "Microbiol Immunol"}, {"key": "10.1111/cas.12152-BIB0050|cas12152-cit-0050", "doi-asserted-by": "crossref", "first-page": "4380", "DOI": "10.1021/jf040045+", "article-title": "Antioxidative and antimutagenic activities of 4-vinyl-2,6-dimethoxyphenol (canolol) isolated from canola oil", "volume": "52", "author": "Kuwahara", "year": "2004", "journal-title": "J Agric Food Chem"}, {"key": "10.1111/cas.12152-BIB0051|cas12152-cit-0051", "doi-asserted-by": "crossref", "first-page": "1445", "DOI": "10.1002/ijc.23245", "article-title": "4-Vinyl-2,6-dimethoxyphenol (canolol) suppresses oxidative stress and gastric carcinogenesis in Helicobacter pylori-infected carcinogen-treated Mongolian gerbils", "volume": "122", "author": "Cao", "year": "2008", "journal-title": "Int J Cancer"}, {"key": "10.1111/cas.12152-BIB0052|cas12152-cit-0052", "first-page": "1007", "article-title": "Nitric oxide and oxygen radicals in infection, inflammation, and cancer", "volume": "63", "author": "Maeda", "year": "1998", "journal-title": "Biochemistry (Moscow)"}, {"key": "10.1111/cas.12152-BIB0053|cas12152-cit-0053", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1016/j.bbrc.2003.10.003", "article-title": "Superoxide generation mediated by 8-nitroguanosine, a highly redox-active nucleic acid derivative", "volume": "311", "author": "Sawa", "year": "2003", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1111/cas.12152-BIB0054|cas12152-cit-0054", "doi-asserted-by": "crossref", "first-page": "1204", "DOI": "10.1111/j.1349-7006.1992.tb02746.x", "article-title": "Evidence of direct generation of oxygen free radicals from heterocyclic amines by NADPH/cytochrome P-450 reductase in vitro", "volume": "83", "author": "Sato", "year": "1992", "journal-title": "Jpn J Cancer Res"}, {"key": "10.1111/cas.12152-BIB0055|cas12152-cit-0055", "doi-asserted-by": "crossref", "first-page": "1716", "DOI": "10.1006/bbrc.1994.2866", "article-title": "Generation of free radicals from neocarzinostatin mediated by NADPH/cytochrome P-450 reductase via activation of enediyne chromophore", "volume": "205", "author": "Sato", "year": "1994", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1111/cas.12152-BIB0056|cas12152-cit-0056", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1002/1438-9312(200207)104:7<439::AID-EJLT439>3.0.CO;2-K", "article-title": "Dietary lipid peroxidation products and DNA damage in colon carcinogenesis", "volume": "104", "author": "Kanazawa", "year": "2002", "journal-title": "Eur J Lipid Sci Technol"}, {"key": "10.1111/cas.12152-BIB0057|cas12152-cit-0057", "author": "Maeda", "first-page": "103", "year": "1995", "volume-title": "Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens"}, {"key": "10.1111/cas.12152-BIB0058|cas12152-cit-0058", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/j.niox.2005.11.001", "article-title": "Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation", "volume": "14", "author": "Niles", "year": "2006", "journal-title": "Nitric Oxide"}, {"key": "10.1111/cas.12152-BIB0059|cas12152-cit-0059", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/j.niox.2005.06.005", "article-title": "Nitrative DNA damage in inflammation and its possible role in carcinogenesis", "volume": "14", "author": "Sawa", "year": "2006", "journal-title": "Nitric Oxide"}, {"key": "10.1111/cas.12152-BIB0060|cas12152-cit-0060", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1038/sj.bjc.6690060", "article-title": "Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells", "volume": "79", "author": "Okada", "year": "1999", "journal-title": "Br J Cancer"}, {"key": "10.1111/cas.12152-BIB0061|cas12152-cit-0061", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.2353/ajpath.2006.060073", "article-title": "The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells", "volume": "169", "author": "Okada", "year": "2006", "journal-title": "Am J Pathol"}, {"key": "10.1111/cas.12152-BIB0062|cas12152-cit-0062", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1016/j.niox.2005.06.009", "article-title": "Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression", "volume": "14", "author": "Okada", "year": "2006", "journal-title": "Nitric Oxide"}, {"key": "10.1111/cas.12152-BIB0063|cas12152-cit-0063", "doi-asserted-by": "crossref", "first-page": "2364", "DOI": "10.1002/ijc.23125", "article-title": "Beyond foreign-body-induced carcinogenesis: impact of reactive oxygen species derived from inflammatory cells in tumorigenic conversion and tumor progression", "volume": "121", "author": "Okada", "year": "2007", "journal-title": "Int J Cancer"}, {"key": "10.1111/cas.12152-BIB0064|cas12152-cit-0064", "doi-asserted-by": "crossref", "first-page": "1201", "DOI": "10.1111/j.1349-7006.2012.02293.x", "article-title": "Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis", "volume": "103", "author": "Shimizu", "year": "2012", "journal-title": "Cancer Sci"}, {"key": "10.1111/cas.12152-BIB0065|cas12152-cit-0065", "doi-asserted-by": "crossref", "first-page": "1561", "DOI": "10.1056/NEJM199606133342402", "article-title": "Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group", "volume": "334", "author": "Muto", "year": "1996", "journal-title": "N Engl J Med"}, {"key": "10.1111/cas.12152-BIB0066|cas12152-cit-0066", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1093/carcin/22.1.193", "article-title": "Inhibition of azoxymethane-induced colon carcinogenesis in male F344 rats by the citrus limonoids obacunone and limonin", "volume": "22", "author": "Tanaka", "year": "2001", "journal-title": "Carcinogenesis"}, {"key": "10.1111/cas.12152-BIB0067|cas12152-cit-0067", "doi-asserted-by": "crossref", "first-page": "768", "DOI": "10.1038/nrc1189", "article-title": "Cancer chemoprevention with dietary phytochemicals", "volume": "3", "author": "Surh", "year": "2003", "journal-title": "Nat Rev Cancer"}, {"key": "10.1111/cas.12152-BIB0068|cas12152-cit-0068", "author": "Weinberg", "year": "2007", "volume-title": "The Biology of Cancer"}, {"key": "10.1111/cas.12152-BIB0069|cas12152-cit-0069", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/S0169-409X(00)00134-4", "article-title": "SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy", "volume": "46", "author": "Maeda", "year": "2001", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1111/cas.12152-BIB0070|cas12152-cit-0070", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1038/bjc.1993.179", "article-title": "Augmentation of tumor delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure", "volume": "67", "author": "Li", "year": "1993", "journal-title": "Br J Cancer"}, {"key": "10.1111/cas.12152-BIB0071|cas12152-cit-0071", "first-page": "2060", "article-title": "Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration", "volume": "40", "author": "Kimura", "year": "1980", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0072|cas12152-cit-0072", "first-page": "2411", "article-title": "Microvascular architecture of experimental colon tumors in the rat", "volume": "50", "author": "Skinner", "year": "1990", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0073|cas12152-cit-0073", "doi-asserted-by": "crossref", "first-page": "1866", "DOI": "10.1111/j.1349-7006.2010.01619.x", "article-title": "In vitro and in vivo evaluation of tumor targeting SMA-pirarubicin micelles: survival improvement and inhibition of liver metastases", "volume": "101", "author": "Daruwalla", "year": "2010", "journal-title": "Cancer Sci"}, {"key": "10.1111/cas.12152-BIB0074|cas12152-cit-0074", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1159/000165380", "article-title": "Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases", "volume": "46", "author": "Daruwalla", "year": "2009", "journal-title": "J Vasc Res"}, {"key": "10.1111/cas.12152-BIB0075|cas12152-cit-0075", "first-page": "2115", "article-title": "Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image", "volume": "44", "author": "Iwai", "year": "1984", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0076|cas12152-cit-0076", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.1021/bc100070g", "article-title": "Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects", "volume": "21", "author": "Maeda", "year": "2010", "journal-title": "Bioconjug Chem"}, {"key": "10.1111/cas.12152-BIB0077|cas12152-cit-0077", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.2183/pjab.88.53", "article-title": "Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting", "volume": "88", "author": "Maeda", "year": "2012", "journal-title": "Proc Jpn Acad Ser B"}, {"key": "10.1111/cas.12152-BIB0078|cas12152-cit-0078", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1016/j.addr.2010.04.009", "article-title": "EPR effect: the unique characteristics of tumor blood vessels for drug delivery, factors involved, its limitation and augmentation", "volume": "63", "author": "Fang", "year": "2011", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1111/cas.12152-BIB0079|cas12152-cit-0079", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/j.addr.2012.10.002", "article-title": "The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo", "volume": "65", "author": "Maeda", "year": "2013", "journal-title": "Adv Drug Deliv Rev"}, {"key": "10.1111/cas.12152-BIB0080|cas12152-cit-0080", "first-page": "459", "article-title": "Visualization of tumors in humans using 67 Ga-citrate and the Anger whole-body scanner, scintillation camera and tomographic scanner", "volume": "11", "author": "Winchell", "year": "1970", "journal-title": "J Nucl Med"}, {"key": "10.1111/cas.12152-BIB0081|cas12152-cit-0081", "first-page": "321", "article-title": "Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver", "volume": "7", "author": "Iwai", "year": "1987", "journal-title": "Anticancer Res"}, {"key": "10.1111/cas.12152-BIB0082|cas12152-cit-0082", "first-page": "2005", "article-title": "Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, SMANCS, for hepatocellular carcinoma", "volume": "9", "author": "Konno", "year": "1982", "journal-title": "Cancer Chemother"}, {"key": "10.1111/cas.12152-BIB0083|cas12152-cit-0083", "doi-asserted-by": "crossref", "first-page": "1053", "DOI": "10.1016/0277-5379(83)90028-7", "article-title": "Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report", "volume": "19", "author": "Konno", "year": "1983", "journal-title": "Eur J Cancer Clin Oncol"}, {"key": "10.1111/cas.12152-BIB0084|cas12152-cit-0084", "doi-asserted-by": "crossref", "first-page": "2367", "DOI": "10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F", "article-title": "Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium", "volume": "54", "author": "Konno", "year": "1984", "journal-title": "Cancer"}, {"key": "10.1111/cas.12152-BIB0085|cas12152-cit-0085", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1002/1097-0142(19850815)56:4<751::AID-CNCR2820560409>3.0.CO;2-Y", "article-title": "Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium", "volume": "56", "author": "Maki", "year": "1985", "journal-title": "Cancer"}, {"key": "10.1111/cas.12152-BIB0086|cas12152-cit-0086", "author": "Konno", "first-page": "343", "year": "1987", "volume-title": "Neoplasms of the Liver", "DOI": "10.1007/978-4-431-68349-0_27", "doi-asserted-by": "crossref"}, {"key": "10.1111/cas.12152-BIB0087|cas12152-cit-0087", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1016/0090-4295(91)80308-T", "article-title": "Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma", "volume": "37", "author": "Kobayashi", "year": "1991", "journal-title": "Urology"}, {"key": "10.1111/cas.12152-BIB0088|cas12152-cit-0088", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1016/S0090-4295(99)00537-3", "article-title": "Long-term survival rate after tumor-targeted chemotherapy with the macromolecular anticancer drug SMANCS in lipid contrast medium for renal cell carcinoma: preoperative therapy for nonmetastatic cases", "volume": "55", "author": "Tsuchiya", "year": "2000", "journal-title": "Urology"}, {"key": "10.1111/cas.12152-BIB0089|cas12152-cit-0089", "doi-asserted-by": "crossref", "first-page": "756", "DOI": "10.1093/jjco/hyp074", "article-title": "Elevating blood pressure as a strategy to increase tumor targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors", "volume": "39", "author": "Nagamitsu", "year": "2009", "journal-title": "Jpn J Clin Oncol"}, {"key": "10.1111/cas.12152-BIB0090|cas12152-cit-0090", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1016/j.jconrel.2012.04.038", "article-title": "Macromolecular therapeutics in cancer treatment: the EPR effect and beyond", "volume": "164", "author": "Maeda", "year": "2012", "journal-title": "J Control Release"}, {"key": "10.1111/cas.12152-BIB0091|cas12152-cit-0091", "first-page": "1233", "article-title": "Microvascular corrosion casting in the study of tumor vascularity: a review", "volume": "9", "author": "Konerding", "year": "1995", "journal-title": "Scanning Microsc"}, {"key": "10.1111/cas.12152-BIB0092|cas12152-cit-0092", "doi-asserted-by": "crossref", "first-page": "1363", "DOI": "10.1016/S0002-9440(10)65006-7", "article-title": "Openings between defective endothelial cells explain tumor vessel leakiness", "volume": "1561", "author": "Hashizume", "year": "2000", "journal-title": "Am J Pathol"}, {"key": "10.1111/cas.12152-BIB0093|cas12152-cit-0093", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1016/S1567-5769(02)00271-0", "article-title": "Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications", "volume": "3", "author": "Maeda", "year": "2003", "journal-title": "Int Immunopharmacol"}, {"key": "10.1111/cas.12152-BIB0094|cas12152-cit-0094", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1016/0162-3109(96)00063-X", "article-title": "Bradykinin and nitric oxide in infectious disease and cancer", "volume": "33", "author": "Maeda", "year": "1996", "journal-title": "Immunopharmacology"}, {"key": "10.1111/cas.12152-BIB0095|cas12152-cit-0095", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1080/1061186031000086072", "article-title": "Modulation of tumor-selective vascular blood flow and extravasation by the stable prostaglandin I2 analogue beraprost sodium", "volume": "11", "author": "Tanaka", "year": "2003", "journal-title": "J Drug Target"}, {"key": "10.1111/cas.12152-BIB0096|cas12152-cit-0096", "doi-asserted-by": "crossref", "first-page": "2426", "DOI": "10.1111/j.1349-7006.2009.01323.x", "article-title": "Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application", "volume": "100", "author": "Seki", "year": "2009", "journal-title": "Cancer Sci"}, {"key": "10.1111/cas.12152-BIB0097|cas12152-cit-0097", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1111/j.1349-7006.2011.02178.x", "article-title": "Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention (EPR) effect of solid tumor", "volume": "102", "author": "Fang", "year": "2012", "journal-title": "Cancer Sci"}, {"key": "10.1111/cas.12152-BIB0098|cas12152-cit-0098", "doi-asserted-by": "crossref", "first-page": "688", "DOI": "10.1200/JCO.2005.04.0436", "article-title": "Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small cell lung cancer", "volume": "24", "author": "Yasuda", "year": "2006", "journal-title": "J Clin Oncol"}, {"key": "10.1111/cas.12152-BIB0099|cas12152-cit-0099", "doi-asserted-by": "crossref", "first-page": "6748", "DOI": "10.1158/1078-0432.CCR-06-1124", "article-title": "Nitroglycerin treatment may increase response to docetaxel and carboplatin regimen via inhibitions of hypoxia-inducible factor-1 pathway and P-glycoprotein in patients with lung adenocarcinoma", "volume": "12", "author": "Yasuda", "year": "2006", "journal-title": "Clin Cancer Res"}, {"key": "10.1111/cas.12152-BIB0100|cas12152-cit-0100", "author": "Yasuda", "first-page": "419", "year": "2010", "volume-title": "Nitric Oxide and Cancer", "DOI": "10.1007/978-1-4419-1432-3_22", "doi-asserted-by": "crossref"}, {"key": "10.1111/cas.12152-BIB0101|cas12152-cit-0101", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1016/S0360-3016(00)00694-5", "article-title": "Changes in tumor oxygenation/perfusion induced by the NO donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI", "volume": "48", "author": "Jordan", "year": "2000", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10.1111/cas.12152-BIB0102|cas12152-cit-0102", "first-page": "5845", "article-title": "Hypoxic mammalian cell radiosensitization by nitric oxide", "volume": "53", "author": "Mitchell", "year": "1993", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0103|cas12152-cit-0103", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1111/j.1349-7006.1992.tb00093.x", "article-title": "T. Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II", "volume": "83", "author": "Noguchi", "year": "1992", "journal-title": "Jpn J Cancer Res"}, {"key": "10.1111/cas.12152-BIB0104|cas12152-cit-0104", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/j.jconrel.2012.11.017", "article-title": "Micelles of zinc protoporphyrin conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer for imaging and light-induced antitumor effects in vivo", "volume": "165", "author": "Nakamura", "year": "2013", "journal-title": "J Control Release"}, {"key": "10.1111/cas.12152-BIB0105|cas12152-cit-0105", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1080/10611860701498252", "article-title": "Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation", "volume": "15", "author": "Iyer", "year": "2007", "journal-title": "J Drug Target"}, {"key": "10.1111/cas.12152-BIB0106|cas12152-cit-0106", "first-page": "17", "article-title": "Reinventing pharma: the theranostic revolution", "volume": "2", "author": "Funkhouser", "year": "2002", "journal-title": "Curr Drug Discov"}, {"key": "10.1111/cas.12152-BIB0107|cas12152-cit-0107", "doi-asserted-by": "crossref", "first-page": "1879", "DOI": "10.1021/bc200151q", "article-title": "Theranostics: combining imaging and therapy", "volume": "22", "author": "Kelkar", "year": "2011", "journal-title": "Bioconjug Chem"}, {"key": "10.1111/cas.12152-BIB0108|cas12152-cit-0108", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1038/sj.gt.3302843", "article-title": "Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid", "volume": "14", "author": "Hatakeyama", "year": "2007", "journal-title": "Gene Ther"}, {"key": "10.1111/cas.12152-BIB0109|cas12152-cit-0109", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1016/j.jconrel.2011.04.025", "article-title": "Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles", "volume": "155", "author": "Nakamura", "year": "2011", "journal-title": "J Control Release"}, {"key": "10.1111/cas.12152-BIB0110|cas12152-cit-0110", "first-page": "3206", "article-title": "Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer", "volume": "47", "author": "Oda", "year": "1987", "journal-title": "Cancer Res"}, {"key": "10.1111/cas.12152-BIB0111|cas12152-cit-0111", "first-page": "1205", "article-title": "Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH", "volume": "9", "author": "Oda", "year": "1987", "journal-title": "J Nat Cancer Inst"}, {"key": "10.1111/cas.12152-BIB0112|cas12152-cit-0112", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.3181/00379727-181-42218", "article-title": "Stimulation of macrophage by polyanions and its conjugated proteins and effect on cell membrane", "volume": "181", "author": "Oda", "year": "1986", "journal-title": "Proc Soc Exp Biol Med"}, {"key": "10.1111/cas.12152-BIB0113|cas12152-cit-0113", "doi-asserted-by": "crossref", "first-page": "2101", "DOI": "10.1021/mp200394t", "article-title": "Nanomedicine(s) under the microscope", "volume": "8", "author": "Duncan", "year": "2011", "journal-title": "Mol Pharm"}, {"key": "10.1111/cas.12152-BIB0114|cas12152-cit-0114", "doi-asserted-by": "crossref", "first-page": "3460", "DOI": "10.1073/pnas.0611660104", "article-title": "Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-\u03b2 signaling", "volume": "104", "author": "Kano", "year": "2007", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1111/cas.12152-BIB0115|cas12152-cit-0115", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/j.jconrel.2011.08.022", "article-title": "Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway", "volume": "156", "author": "Seki", "year": "2011", "journal-title": "J Control Release"}, {"key": "10.1111/cas.12152-BIB0116|cas12152-cit-0116", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1016/j.nantod.2012.04.002", "article-title": "Guided delivery of polymer therapeutics using plasmonic photothermal therapy", "volume": "7", "author": "Gormley", "year": "2012", "journal-title": "Nano Today"}], "container-title": ["Cancer Science"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcas.12152", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 11]], "date-time": "2019-07-11T02:20:29Z", "timestamp": 1562811629000}, "score": 27.651901, "issued": {"date-parts": [[2013, 4, 22]]}, "references-count": 116, "journal-issue": {"published-print": {"date-parts": [[2013, 7]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.1111/cas.12152", "relation": {"cites": []}, "ISSN": ["1347-9032"], "issn-type": [{"value": "1347-9032", "type": "print"}], "subject": ["Cancer Research", "Oncology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T03:48:16Z", "timestamp": 1574308096792}, "publisher-location": "New York, NY", "reference-count": 117, "publisher": "Springer US", "isbn-type": [{"value": "9781441901309", "type": "print"}, {"value": "9781441901316", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-1-4419-0131-6_3", "type": "book-chapter", "created": {"date-parts": [[2009, 6, 22]], "date-time": "2009-06-22T23:30:14Z", "timestamp": 1245713414000}, "page": "93-120", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor"], "prefix": "10.1007", "author": [{"given": "Takahiro", "family": "Seki", "sequence": "first", "affiliation": []}, {"given": "Jun", "family": "Fang", "sequence": "additional", "affiliation": []}, {"given": "Hiroshi", "family": "Maeda", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 6, 8]]}, "reference": [{"key": "3_CR1", "unstructured": "\u201cWorld Health Organization\u201d report. 2008. Available from: \n                http://www.who.int/cancer/en\n                \n              /"}, {"key": "3_CR2", "first-page": "76", "volume": "149", "author": "CF Leaf", "year": "2005", "unstructured": "Leaf CF. Why we are losing the war on cancer and how to win it. Fortune 2005; 149: 76\u201397.", "journal-title": "Fortune"}, {"key": "3_CR3", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1038/nbt0505-535", "volume": "23", "author": "GLG Miklos", "year": "2005", "unstructured": "Miklos, GLG. The human cancer genome project-one more misstep in the war on cancer. Nat Biotechnol 2005; 23: 535\u2013537.", "journal-title": "Nat Biotechnol"}, {"key": "3_CR4", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1016/S0140-6736(07)60004-X", "volume": "369", "author": "D Hind", "year": "2007", "unstructured": "Hind D, Pilgrim H, Ward S. Questions about adjuvant trastuzumab still remain. The Lancet 2007; 369: 3\u20135.", "journal-title": "The Lancet"}, {"key": "3_CR5", "doi-asserted-by": "publisher", "first-page": "750", "DOI": "10.1038/nrc903", "volume": "2", "author": "TM Allen", "year": "2002", "unstructured": "Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002; 2: 750\u2013765.", "journal-title": "Nat Rev Cancer"}, {"key": "3_CR6", "doi-asserted-by": "publisher", "first-page": "268", "DOI": "10.1126/science.1133427", "volume": "314", "author": "T Sj\u00f6blom", "year": "2006", "unstructured": "Sj\u00f6blom T, Jones S, Wood LD, Parsons W, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JKV, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268\u2013274.", "journal-title": "Science"}, {"key": "3_CR7", "doi-asserted-by": "crossref", "first-page": "1108", "DOI": "10.1126/science.1145720", "volume": "318", "author": "LD Wood", "year": "2007", "unstructured": "Wood LD, Parsons DW, Jones S, Lin J, Sj\u00f6blom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JKV, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PVK, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B. Science 2007; 318: 1108\u20131113.", "journal-title": "Science"}, {"key": "3_CR8", "first-page": "18", "volume": "2", "author": "A Jack", "year": "2008", "unstructured": "Jack A, Simonian H. Roche to switch to primary care force. Financial Times, European Ed. 2008; July 2: 18.", "journal-title": "Financial Times, European Ed"}, {"key": "3_CR9", "author": "D Rabinovitch", "year": "2007", "unstructured": "Rabinovitch D. Take Off Your Dress. London, Simon & Schuster; 2007.", "volume-title": "Take Off Your Dress"}, {"key": "3_CR10", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1016/S0140-6736(08)61249-0", "volume": "372", "author": "Editorial", "year": "2008", "unstructured": "Editorial. Welcome clinical leadership at NICE. The Lancet 2008; 372: 601.", "journal-title": "The Lancet"}, {"key": "3_CR11", "unstructured": "Office of Fair Trading report. 2007. [Available from: \n                http://www.oft.gov.uk/shared_oft/reports/comp_policy/oft885.pdf\n                \n              ]"}, {"key": "3_CR12", "doi-asserted-by": "crossref", "first-page": "1108", "DOI": "10.1093/jnci/djj305", "volume": "98", "author": "MJ Hassett", "year": "2006", "unstructured": "Hassett MJ, O\u2019Malley J, Pakes JR, Newhouse JP, Earle CC. J Natl Cancer Inst 2006; 98: 1108\u20131117.", "journal-title": "J Natl Cancer Inst"}, {"key": "3_CR13", "author": "M Angell", "year": "2004", "unstructured": "Angell M. The Truth About the Drug Companies. New York, Random House, 2004.", "volume-title": "The Truth About the Drug Companies"}, {"key": "3_CR14", "first-page": "6387", "volume": "46", "author": "Y Matsumura", "year": "1986", "unstructured": "Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387\u20136392.", "journal-title": "Cancer Res"}, {"key": "3_CR15", "first-page": "193", "volume": "6", "author": "H Maeda", "year": "1989", "unstructured": "Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989; 6: 193\u2013210.", "journal-title": "Crit Rev Ther Drug Carrier Syst"}, {"key": "3_CR16", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1016/S0168-3659(01)00309-1", "volume": "74", "author": "H Maeda", "year": "2001", "unstructured": "Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001; 74: 47\u201361.", "journal-title": "J Control Release"}, {"key": "3_CR17", "first-page": "2115", "volume": "44", "author": "K Iwai", "year": "1984", "unstructured": "K. Iwai, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res 1984; 44: 2115\u20132121.", "journal-title": "Cancer Res"}, {"key": "3_CR18", "first-page": "321", "volume": "7", "author": "K Iwai", "year": "1987", "unstructured": "Iwai K, Maeda H, Konno T, Matsumura Y, Yamashita R, Yamasaki K, Hirayama S, Miyauchi Y. Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver. Anticancer Res 1987; 7: 321\u2013327.", "journal-title": "Anticancer Res"}, {"key": "3_CR19", "doi-asserted-by": "crossref", "first-page": "2367", "DOI": "10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F", "volume": "54", "author": "T Konno", "year": "1984", "unstructured": "Konno T, Maeda H, Iwai K, Maki S, Tashiro S, Uchida M, Miyauchi Y. Cancer 1984; 54: 2367\u20132374.", "journal-title": "Cancer"}, {"key": "3_CR20", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1002/1097-0142(19850815)56:4<751::AID-CNCR2820560409>3.0.CO;2-Y", "volume": "56", "author": "S Maki", "year": "1985", "unstructured": "Maki S, Konno T, Maeda H. Image enhancement in computerized tomography for selective diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 1985; 56: 751\u2013757.", "journal-title": "Cancer"}, {"key": "3_CR21", "doi-asserted-by": "publisher", "first-page": "1089", "DOI": "10.2165/00003088-200342130-00002", "volume": "42", "author": "K Greish", "year": "2003", "unstructured": "Greish K, Fang J, Inutsuka T, Nagamitsu A, Maeda H. Macromolecular Therapeutics: Advantages and prospects with special emphasis on solid tumour targeting. Clin Pharmacokinet 2003; 42: 1089\u20131105.", "journal-title": "Clin Pharmacokinet"}, {"key": "3_CR22", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.2745/dds.22.510", "volume": "22-5", "author": "A Nagamitsu", "year": "2007", "unstructured": "Nagamitsu A, Inuzuka T, Greish K, Maeda H. SMANCS dynamic therapy for various advanced solid tumors and promising clinical effects: Enhanced drug delivery by hydrodynamic modulation with vascular mediators, particularly angiotensin II, during arterial infusion. Drug Deliv Sys 2007; 22-5: 510\u2013521. In Japanese.", "journal-title": "Drug Deliv Sys"}, {"key": "3_CR23", "first-page": "243", "volume": "7", "author": "KJ Harrington", "year": "2001", "unstructured": "Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Stewart JSW. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 2001; 7: 243\u2013254.", "journal-title": "Clin Cancer Res"}, {"key": "3_CR24", "doi-asserted-by": "publisher", "first-page": "4", "DOI": "10.1093/jnci/82.1.4", "volume": "82", "author": "J Folkman", "year": "1990", "unstructured": "Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4\u20136.", "journal-title": "J Natl Cancer Inst"}, {"key": "3_CR25", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1038/nm0195-27", "volume": "1", "author": "J Folkman", "year": "1995", "unstructured": "Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27\u201330.", "journal-title": "Nat Med"}, {"key": "3_CR26", "first-page": "2411", "volume": "50", "author": "SA Skinner", "year": "1990", "unstructured": "Skinner SA, Tutton PJM, O\u2019Brien PE. Microvascular architecture of experimental colon tumors in the rat. Cancer Res 1990; 50: 2411\u20132417.", "journal-title": "Cancer Res"}, {"key": "3_CR27", "first-page": "213", "volume": "138", "author": "TA Brock", "year": "1991", "unstructured": "Brock TA, Dvorak HF, Sengar DR. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991; 138: 213\u2013221.", "journal-title": "Am J Pathol"}, {"key": "3_CR28", "doi-asserted-by": "publisher", "first-page": "1363", "DOI": "10.1016/S0002-9440(10)65006-7", "volume": "156", "author": "H Hashizume", "year": "2000", "unstructured": "Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156: 1363\u20131380.", "journal-title": "Am J Pathol"}, {"key": "3_CR29", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1111/j.1349-7006.1998.tb00563.x", "volume": "89", "author": "Y Noguchi", "year": "1998", "unstructured": "Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, Maeda H. Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 1998; 89: 307\u2013314.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR30", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1016/S0169-409X(00)00134-4", "volume": "46", "author": "H Maeda", "year": "2001", "unstructured": "Maeda H. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev 2001; 46: 169\u2013185.", "journal-title": "Adv Drug Deliv Rev"}, {"key": "3_CR31", "doi-asserted-by": "publisher", "first-page": "271", "DOI": "10.1016/S0168-3659(99)00248-5", "volume": "65", "author": "H Maeda", "year": "2000", "unstructured": "Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effects in macromolecular therapeutics: a review. J Control Release 2000; 65: 271\u2013284.", "journal-title": "J Control Release"}, {"key": "3_CR32", "first-page": "2061", "volume": "40", "author": "NT Kimura", "year": "1980", "unstructured": "Kimura NT, Taniguchi S, Aoki K, Baba T. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res 1980; 40: 2061\u20132068.", "journal-title": "Cancer Res"}, {"key": "3_CR33", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1093/oxfordjournals.jbchem.a134892", "volume": "96", "author": "K Matsumoto", "year": "1984", "unstructured": "Matsumoto K, Yamamoto T, Kamata R, Maeda H. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease. J Biochem 1984; 96: 739\u2013749.", "journal-title": "J Biochem"}, {"key": "3_CR34", "first-page": "10589", "volume": "264", "author": "A Molla", "year": "1989", "unstructured": "Molla A, Yamamoto T, Akaike T, Miyoshi S, Maeda H. Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J Biol Chem 1989; 264: 10589\u201310594.", "journal-title": "J Biol Chem"}, {"key": "3_CR35", "first-page": "17711", "volume": "268", "author": "K Maruo", "year": "1993", "unstructured": "Maruo K, Akaike T, Inada Y, Ohkubo I, Ono T, Maeda H. Effect of microbial and mite proteases on low and high molecular weight kininogens. J Biol Chem 1993; 268: 17711\u201317715.", "journal-title": "J Biol Chem"}, {"key": "3_CR36", "doi-asserted-by": "publisher", "first-page": "1327", "DOI": "10.1111/j.1349-7006.1988.tb01563.x", "volume": "79", "author": "Y Matsumura", "year": "1988", "unstructured": "Matsumura Y, Kimura M, Yamamoto T, Maeda H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res 1988; 79: 1327\u20131334.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR37", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.1111/j.1349-7006.1991.tb01910.x", "volume": "82", "author": "Y Matsumura", "year": "1991", "unstructured": "Matsumura Y, Maruo K, Kimura M, Yamamoto T, Konno T, Maeda H. Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn J Cancer Res 1991; 82: 732\u2013741.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR38", "first-page": "16051", "volume": "263", "author": "H Maeda", "year": "1988", "unstructured": "Maeda H, Matsumura Y, Kato H. Purification and identification of [hydroxyprolyl3]bradykinin in ascetic fluid from a patient with gastric cancer. J Biol Chem 1988; 263: 16051\u201316054.", "journal-title": "J Biol Chem"}, {"key": "3_CR39", "doi-asserted-by": "publisher", "first-page": "1103", "DOI": "10.1515/BC.2000.135", "volume": "381", "author": "J Plendl", "year": "2000", "unstructured": "Plendl J, Snyman C, Naidoo S, Sawant S, Mahabeer R, Bhoola KD. Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells. Biol Chem 2000; 381: 1103\u20131115.", "journal-title": "Biol Chem"}, {"key": "3_CR40", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1002/ijc.10142", "volume": "98", "author": "J Wu", "year": "2002", "unstructured": "Wu J Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K, M\u00fcller-Esterl W and Maeda H. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 2002; 98: 29\u201335.", "journal-title": "Int J Cancer"}, {"key": "3_CR41", "first-page": "159", "volume": "58", "author": "J Wu", "year": "1998", "unstructured": "Wu J, Akaike T, Maeda H. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and nitric oxide scavenger. Cancer Res 1998; 58: 159\u2013165.", "journal-title": "Cancer Res"}, {"key": "3_CR42", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1111/j.1349-7006.1994.tb02362.x", "volume": "85", "author": "H Maeda", "year": "1994", "unstructured": "Maeda H, Noguchi Y, Sato K, Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 1994; 85: 331\u2013334.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR43", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/S0162-3109(99)00104-6", "volume": "43", "author": "H Maeda", "year": "1999", "unstructured": "Maeda H, Wu J, Okamoto T, Maruo K, Akaike T. Kallikrein-kinin in infection and cancer. Immunopharmacology 1999; 43: 115\u2013128.", "journal-title": "Immunopharmacology"}, {"key": "3_CR44", "doi-asserted-by": "publisher", "first-page": "1169", "DOI": "10.1038/bjc.1995.228", "volume": "71", "author": "RE Meyer", "year": "1995", "unstructured": "Meyer RE, Shan S, DeAngelo J, Dodge RK, Bonaventura J, Ong ET, Dewhirst MW. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br J Cancer 1995; 71: 1169\u20131174.", "journal-title": "Br J Cancer"}, {"key": "3_CR45", "first-page": "948", "volume": "57", "author": "GM Tozer", "year": "1997", "unstructured": "Tozer GM, Prise VE, Chaplin DJ. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res 1997; 57: 948\u2013955.", "journal-title": "Cancer Res"}, {"key": "3_CR46", "doi-asserted-by": "publisher", "first-page": "29596", "DOI": "10.1074/jbc.M102417200", "volume": "276", "author": "T Okamoto", "year": "2001", "unstructured": "Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 2001; 276: 29596\u201329602.", "journal-title": "J Biol Chem"}, {"key": "3_CR47", "unstructured": "Liotta LA, Kohn EC. Invasion and metastases. In: RC Bast Jr, JF HollanD, E Frei, et al. (eds) Cancer Medicine, ed. 5. Hamilton: B.C. Decker Inc, pp. 121\u2013131, 2000."}, {"key": "3_CR48", "doi-asserted-by": "publisher", "first-page": "1260", "DOI": "10.1093/jnci/89.17.1260", "volume": "89", "author": "AF Chambers", "year": "1997", "unstructured": "Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260\u20131270.", "journal-title": "J Natl Cancer Inst"}, {"key": "3_CR49", "doi-asserted-by": "publisher", "first-page": "439", "DOI": "10.1111/j.1349-7006.2001.tb01114.x", "volume": "92", "author": "J Wu", "year": "2001", "unstructured": "Wu J, Akaike T, Hayashida K, Okamoto T, Okuyama A and Maeda H. Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn J Cancer Res 2001; 92: 439\u2013451.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR50", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1016/S1567-5769(02)00271-0", "volume": "3", "author": "H Maeda", "year": "2003", "unstructured": "H. Maeda, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 2003; 3: 319\u2013328.", "journal-title": "Int Immunopharmacol"}, {"key": "3_CR51", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1126/science.6823562", "volume": "219", "author": "DR Senger", "year": "1983", "unstructured": "Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983\u2013985.", "journal-title": "Science"}, {"key": "3_CR52", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1007/978-3-642-59953-8_6", "volume": "237", "author": "HF Dvorak", "year": "1999", "unstructured": "Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999; 237: 97\u2013132.", "journal-title": "Curr Top Microbiol Immunol"}, {"key": "3_CR53", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1080/1061186031000086072", "volume": "1", "author": "S Tanaka", "year": "2003", "unstructured": "Tanaka S, Akaike T, Wu J, Fang J, Sawa T, Ogawa M, Beppu T, Maeda H. Modulation of tumor-selective vascular blood flow and extravasation by the stable prostaglandin I2 analogue beraprost sodium. J Drug Target 2003; 1: 45\u201352.", "journal-title": "J Drug Target"}, {"key": "3_CR54", "doi-asserted-by": "publisher", "first-page": "688", "DOI": "10.1038/nrc1958", "volume": "6", "author": "R Duncan", "year": "2006", "unstructured": "Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006; 6: 688\u2013701.", "journal-title": "Nat Rev Cancer"}, {"key": "3_CR55", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1038/nnano.2007.387", "volume": "2", "author": "D Peer", "year": "2007", "unstructured": "Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotech 2007; 2: 751\u2013760.", "journal-title": "Nat Nanotech"}, {"key": "3_CR56", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1016/S0169-409X(02)00017-0", "volume": "54", "author": "Y Kakizawa", "year": "2002", "unstructured": "Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev 2002; 54: 203\u2013222.", "journal-title": "Adv Drug Deliv"}, {"key": "3_CR57", "doi-asserted-by": "publisher", "first-page": "771", "DOI": "10.1038/nrd2614", "volume": "7", "author": "ME Davis", "year": "2008", "unstructured": "Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7: 771\u2013782.", "journal-title": "Nat Rev Drug Discov"}, {"key": "3_CR58", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1016/j.tibtech.2005.11.006", "volume": "24", "author": "MJ Vicent", "year": "2006", "unstructured": "Vicent MJ, Duncan R. Polymer conjugates: Nanosized medicines for treating cancer. Trend Biotechnol 2006; 24: 39\u201347.", "journal-title": "Trend Biotechnol"}, {"key": "3_CR59", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1007/BF01040499", "volume": "3", "author": "H Maeda", "year": "1984", "unstructured": "Maeda H, Matsumoto T, Konno T, Iwai K, Ueda M. Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs. J Protein Chem 1984; 3: 181\u2013193.", "journal-title": "J Protein Chem"}, {"key": "3_CR60", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1111/j.1399-3011.1979.tb01730.x", "volume": "14", "author": "H Maeda", "year": "1979", "unstructured": "Maeda H, Takeshita J, Kanamaru R. A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic. Int J Pept Protein Res 1979; 14: 81\u201387.", "journal-title": "Int J Pept Protein Res"}, {"key": "3_CR61", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1021/jm00382a012", "volume": "28", "author": "H Maeda", "year": "1985", "unstructured": "Maeda H, Ueda M, Morinaga T, Matsumoto T. Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: Pronounced improvements in pharmacological properties. J Med Chem 1985; 28: 455\u2013461.", "journal-title": "J Med Chem"}, {"key": "3_CR62", "first-page": "663", "volume": "67", "author": "M Suzuki", "year": "1981", "unstructured": "Suzuki M, Hori K, Abe I, Saito S, Sato H. A new approach to cancer chemotherapy: A selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 1981; 67: 663\u2013669.", "journal-title": "J Natl Cancer Inst"}, {"key": "3_CR63", "doi-asserted-by": "publisher", "first-page": "1309", "DOI": "10.1111/j.1349-7006.1991.tb01797.x", "volume": "82", "author": "K Hori", "year": "1991", "unstructured": "Hori K, Suzuki M, Tanda S, Saito D, Shinozaki M, Zhang QH. Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension. Jpn J Cancer Res 1991; 82: 1309\u20131316.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR64", "doi-asserted-by": "publisher", "first-page": "975", "DOI": "10.1038/bjc.1993.179", "volume": "67", "author": "CJ Li", "year": "1993", "unstructured": "Li CJ, Miyamoto Y, Kojima Y, Maeda H. Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure. Br J Cancer 1993; 67: 975\u2013980.", "journal-title": "Br J Cancer"}, {"key": "3_CR65", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1111/j.1349-7006.2000.tb00940.x", "volume": "91", "author": "K Hori", "year": "2000", "unstructured": "Hori K, Saito S, Takahashi H, Sato H, Maeda H, Sato Y. Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride. Jpn J Cancer Res 2000; 91: 261\u2013269.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR66", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1002/ijc.2910150503", "volume": "15", "author": "HR Strausser", "year": "1975", "unstructured": "Strausser HR, Humes JL. Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in balb/c mice. Int J Cancer 1975; 15: 724\u2013730.", "journal-title": "Int J Cancer"}, {"key": "3_CR67", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1038/bjc.1980.56", "volume": "41", "author": "A Trevisani", "year": "1980", "unstructured": "Trevisani A, Ferretti E, Capuzzo A, Tomasi V. Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br J Cancer 1980; 41: 341\u2013347.", "journal-title": "Br J Cancer"}, {"key": "3_CR68", "doi-asserted-by": "publisher", "first-page": "S68", "DOI": "10.1016/j.niox.2008.06.204", "volume": "19", "author": "T Seki", "year": "2008", "unstructured": "Seki T, Fang J, and Maeda H. Enhanced antitumor drug-delivery by topical applications of nitroglycerine on superficial tumors. Nitric Oxide 2008; 19: S68.", "journal-title": "Nitric Oxide"}, {"key": "3_CR69", "doi-asserted-by": "publisher", "first-page": "S81", "DOI": "10.1016/S0928-0987(00)00166-4", "volume": "11", "author": "VP Torchilin", "year": "2000", "unstructured": "Torchilin VP. Drug targeting. Eur J Pharmaceut Sci 2000; 11: S81\u2013S91.", "journal-title": "Eur J Pharmaceut Sci"}, {"key": "3_CR70", "first-page": "554", "volume": "35", "author": "H Maeda", "year": "1975", "unstructured": "Maeda H, Aikawa S, Yamashita A. Subcellular fate of protein antibiotic neocarzinostatin in culture of a lymphoid cell line from Burkitt\u2019s lymphoma. Cancer Res 1975; 35: 554\u2013559.", "journal-title": "Cancer Res"}, {"key": "3_CR71", "first-page": "3206", "volume": "47", "author": "T Oda", "year": "1987", "unstructured": "Oda T, Maeda H. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer. Cancer Res 1987; 47: 3206\u20133211.", "journal-title": "Cancer Res"}, {"key": "3_CR72", "first-page": "1571", "volume": "50", "author": "Y Miyamoto", "year": "1990", "unstructured": "Miyamoto Y, Oda T, Maeda H. Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro. Cancer Res 1990; 50: 1571\u20131575.", "journal-title": "Cancer Res"}, {"key": "3_CR73", "doi-asserted-by": "publisher", "first-page": "1226", "DOI": "10.1021/bc060145g", "volume": "17", "author": "CP Leamon", "year": "2006", "unstructured": "Leamon CP, Reddy JA, Vlahov IR, Kleindl PJ, Vetzel M, Westrick E. Synthesis and biological evaluation of EC140: A novel folate-targeted vinca alkaloid conjugate. Bioconjug Chem 2006; 17: 1226\u20131232.", "journal-title": "Bioconjug Chem"}, {"key": "3_CR74", "doi-asserted-by": "publisher", "first-page": "1314", "DOI": "10.1021/bc060064k", "volume": "17", "author": "Y Miyajima", "year": "2006", "unstructured": "Miyajima Y, Nakamura H, Kuwata Y, Lee JD, Masunaga S, Ono K, Maruyama K. Transferrin-loaded nido-carborane liposomes: Tumor-targeting boron delivery system for neutron capture therapy. Bioconjug Chem 2006; 17: 1314\u20131320.", "journal-title": "Bioconjug Chem"}, {"key": "3_CR75", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1091/mbc.01-06-0280", "volume": "13", "author": "P Pellegrin", "year": "2002", "unstructured": "Pellegrin P, Fernandez A, Lamb NJC, Bennes R. Macromolecular uptake is a spontaneous event during mitosis in cultured fibroblasts: Implications for vector-dependent plasmid transfection. Mol Biol Cell 2002; 13: 570\u2013578.", "journal-title": "Mol Biol Cell"}, {"key": "3_CR76", "doi-asserted-by": "publisher", "first-page": "537", "DOI": "10.1007/s00280-006-0296-4", "volume": "59", "author": "SA Shaffer", "year": "2007", "unstructured": "Shaffer SA, Baker-Lee C, Kennedy J, Lai MS, de Vries P, Buhler K, Singer JW. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases. Cancer Chemother Pharmacol 2007; 59: 537\u2013548.", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "3_CR77", "doi-asserted-by": "publisher", "first-page": "441", "DOI": "10.1016/S1461-5347(99)00211-4", "volume": "2", "author": "R Duncan", "year": "1999", "unstructured": "Duncan R. Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm Sci Technol Today 1999; 2: 441\u2013449.", "journal-title": "Pharm Sci Technol Today"}, {"key": "3_CR78", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1038/nrd1088", "volume": "2", "author": "R Duncan", "year": "2003", "unstructured": "Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003; 2: 347\u2013360.", "journal-title": "Nat Rev Drug Discov"}, {"key": "3_CR79", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/S0168-3659(01)00328-5", "volume": "74", "author": "R Duncan", "year": "2001", "unstructured": "Duncan R, Gac-Breton S, Keane R, Musila R, Sat YN, Satchi R, Searle F. Polymer-drug conjugates, PDEPT and PELT: Basic principles for design and transfer from the laboratory to clinic. J Control Release 2001; 74: 135\u2013146.", "journal-title": "J Control Release"}, {"key": "3_CR80", "doi-asserted-by": "publisher", "first-page": "332", "DOI": "10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I", "volume": "23", "author": "P Ferruti", "year": "2002", "unstructured": "Ferruti P, Marchisio MA, Duncan R. Poly(amido-amine)s: Biomedical applications. Macromol Rapid Commun 2002; 23: 332\u2013355.", "journal-title": "Macromol Rapid Commun"}, {"key": "3_CR81", "doi-asserted-by": "publisher", "first-page": "230", "DOI": "10.1021/bc040297g", "volume": "16", "author": "K Greish", "year": "2005", "unstructured": "Greish K, Nagamitsu A, Fang J, Maeda H. Copoly(styrene-maleic acid)-pirarubicin micelles: High tumor-targeting efficiency with little toxicity. Bioconjug Chem 2005; 16: 230\u2013236.", "journal-title": "Bioconjug Chem"}, {"key": "3_CR82", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1016/j.jconrel.2004.03.027", "volume": "97", "author": "K Greish", "year": "2004", "unstructured": "Greish K, Sawa T, Fang J, Akaike T, Maeda H. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. J Control Release 2004; 97: 219\u2013230.", "journal-title": "J Control Release"}, {"key": "3_CR83", "doi-asserted-by": "publisher", "first-page": "1775", "DOI": "10.1038/sj.bjc.6602204", "volume": "91", "author": "Y Matsumura", "year": "2004", "unstructured": "Matsumura Y, Hamaguchi T, Ura T, Muro K, Yamada Y, Shimada Y, Shirao K, Okusaka T, Ueno H, Ikeda M, Watanabe N. Phase I clinical trial and pharmacokinetic evaluation of NK911 amicelle-encapsulated doxorubicin. Br J Cancer 2004; 91: 1775\u20131781.", "journal-title": "Br J Cancer"}, {"key": "3_CR84", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.2165/00003088-200342050-00002", "volume": "42", "author": "A Gabizon", "year": "2003", "unstructured": "Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin. Clin Pharmacokinet 2003; 42: 419\u2013436.", "journal-title": "Clin Pharmacokinet"}, {"key": "3_CR85", "doi-asserted-by": "publisher", "first-page": "351", "DOI": "10.1111/j.1349-7006.1991.tb01853.x", "volume": "82", "author": "Y Miyamoto", "year": "1991", "unstructured": "Miyamoto Y, Maeda H. Enhancement by verapamil of neocarzinostatin action on multidrug-resistant Chinese ovary cells: Possible release of nonprotein chromophore in cells. Jpn J Cancer Res 1991; 82: 351\u2013356.", "journal-title": "Jpn J Cancer Res"}, {"key": "3_CR86", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1016/S0959-8049(98)00373-6", "volume": "35", "author": "M \u0160t'astn\u00fd", "year": "1999", "unstructured": "\u0160t'astn\u00fd M, Strohalm J, Plocov\u00e1 D, Ulbrich K, \u0158\u00edhov\u00e1 B. A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier. Eur J Cancer 1999; 35: 459\u2013466.", "journal-title": "Eur J Cancer"}, {"key": "3_CR87", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1016/S0168-3659(98)00009-1", "volume": "54", "author": "T Minko", "year": "1998", "unstructured": "Minko T, Kope\u010dkov\u00e1 P, Pozharov V, Kope\u010dek J. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release 1998; 54: 223\u2013233.", "journal-title": "J Control Release"}, {"key": "3_CR88", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1016/j.jconrel.2005.03.019", "volume": "105", "author": "T Minko", "year": "2005", "unstructured": "Minko T, Batrakova EV, Li S, Li Y, Pakunlu RI, Alakhov VY, Kabanov AV. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J Control Release 2005; 105: 269\u2013278.", "journal-title": "J Control Release"}, {"key": "3_CR89", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1080/10611860701499946", "volume": "15", "author": "S Zalipsky", "year": "2007", "unstructured": "Zalipsky S, Saad M, Kiwan R, Ber E, Yu N, Minko T. Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action. J Drug Target 2007; 15: 518\u2013530.", "journal-title": "J Drug Target"}, {"key": "3_CR90", "first-page": "2404", "volume": "58", "author": "C Li", "year": "1998", "unstructured": "Li C, Yu DF, Newman RA, Cabral F, Stephens LC, Hunter N, Milas L, Wallace S. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res 1998; 58: 2404\u20132409.", "journal-title": "Cancer Res"}, {"key": "3_CR91", "first-page": "2829", "volume": "6", "author": "C Li", "year": "2000", "unstructured": "Li C, Ke S, Wu QP, Tansey W, Hunter N, Buchmiller LM, Milas L, Charnsangavej C, Wallace S. Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy. Clin Cancer Res 2000; 6: 2829\u20132834.", "journal-title": "Clin Cancer Res"}, {"key": "3_CR92", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1080/10611860701499888", "volume": "15", "author": "Y Matsumura", "year": "2007", "unstructured": "Matsumura Y. Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles. J Drug Target 2007; 15: 507\u2013517.", "journal-title": "J Drug Target"}, {"key": "3_CR93", "first-page": "2643", "volume": "32", "author": "LH Li", "year": "1972", "unstructured": "Li LH, Fraser TJ, Olin EJ, Bhuyan BK. Action of camptothecin on mammalian cells in culture. Cancer Res 1972; 32: 2643\u20132650.", "journal-title": "Cancer Res"}, {"key": "3_CR94", "first-page": "789", "volume": "46", "author": "RC Gallo", "year": "1971", "unstructured": "Gallo RC, Whang-Peng J, Adamson RH. Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J Natl Cancer Inst 1971; 46: 789\u2013795.", "journal-title": "J Natl Cancer Inst"}, {"key": "3_CR95", "first-page": "3229", "volume": "51", "author": "M Yokoyama", "year": "1991", "unstructured": "Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 1991; 51: 3229\u20133236.", "journal-title": "Cancer Res"}, {"key": "3_CR96", "doi-asserted-by": "publisher", "first-page": "10048", "DOI": "10.1158/0008-5472.CAN-06-1605", "volume": "66", "author": "F Koizumi", "year": "2006", "unstructured": "Koizumi F, Kitagawa M, Negishi T, Onda T, Matsumoto S, Hamaguchi T, Matsumura Y. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res 2006; 66: 10048\u201310056.", "journal-title": "Cancer Res"}, {"key": "3_CR97", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1016/0168-3659(90)90139-K", "volume": "11", "author": "M Yokoyama", "year": "1990", "unstructured": "Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S. Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. J Control Release 1990; 11: 269\u2013278.", "journal-title": "J Control Release"}, {"key": "3_CR98", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1016/0168-3659(93)90172-2", "volume": "24", "author": "K Kataoka", "year": "1993", "unstructured": "Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J Control Release 1993; 24: 119\u2013132.", "journal-title": "J Control Release"}, {"key": "3_CR99", "doi-asserted-by": "publisher", "first-page": "170", "DOI": "10.1038/sj.bjc.6603855", "volume": "97", "author": "T Hamaguchi", "year": "2007", "unstructured": "Hamaguchi T, Kato K, Yasui H, Morizane C, Ikeda M, Ueno H, Muro K, Yamada Y, Okusaka T, Shirao K, Shimada Y, Nakahama H, Matsumura Y. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br J Cancer 2007; 97: 170\u2013176.", "journal-title": "Br J Cancer"}, {"key": "3_CR100", "doi-asserted-by": "publisher", "first-page": "899", "DOI": "10.1016/j.addr.2007.11.010", "volume": "60", "author": "Y Mastumura", "year": "2008", "unstructured": "Mastumura Y. Poly(amino acid) micelle nanocarriers in preclinical and clinical studies. Adv Drug Del Rev 2008; 60: 899\u2013914.", "journal-title": "Adv Drug Del Rev"}, {"key": "3_CR101", "first-page": "8977", "volume": "63", "author": "N Nishiyama", "year": "2003", "unstructured": "Nishiyama N, Okazaki S, Cabral H, Miyamoto M, Kato Y, Sugiyama Y, Nishio K, Matsumura Y, Kataoka K. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 2003; 63: 8977\u20138983.", "journal-title": "Cancer Res"}, {"key": "3_CR102", "doi-asserted-by": "publisher", "first-page": "678", "DOI": "10.1038/sj.bjc.6602772", "volume": "93", "author": "H Uchino", "year": "2005", "unstructured": "Uchino H, Matsumura Y, Negishi T, Koizumi F, Hayashi T, Honda T, Nishiyama N, Kataoka K, Naito S, Kakizoe T. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br J Cancer 2005; 93: 678\u2013687.", "journal-title": "Br J Cancer"}, {"key": "3_CR103", "doi-asserted-by": "publisher", "first-page": "1042", "DOI": "10.1023/A:1010960900254", "volume": "18", "author": "O Ishida", "year": "2001", "unstructured": "Ishida O, Maruyama K, Tanahashi H, Iwatsuru M, Sasaki K, Eriguchi M, Yanagie H. Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharmaceutical Res 2001; 18: 1042\u20131048.", "journal-title": "Pharmaceutical Res"}, {"key": "3_CR104", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/j.ijpharm.2007.06.010", "volume": "346", "author": "R Suzuki", "year": "2008", "unstructured": "Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoguchi N, Shinohara A, Eriguchi M, Yanagie H, Maruyama K. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm 2008; 346: 143\u2013150.", "journal-title": "Int J Pharm"}, {"key": "3_CR105", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1182/blood-2006-10-054411", "volume": "110", "author": "R Kondo", "year": "2007", "unstructured": "Kondo R, Gleixner KV, Mayerhofer M, Vales A, Gruze A, Samorapoompichit P, Greish K, Krauth MT, Aichberger KJ, Pickl WF, Esterbauer H, Sillaber C, Maeda H, Valent P. Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells. Blood 2007; 110: 661\u2013669.", "journal-title": "Blood"}, {"key": "3_CR106", "doi-asserted-by": "publisher", "first-page": "1945", "DOI": "10.1038/sj.bjc.6690624", "volume": "80", "author": "K Doi", "year": "1999", "unstructured": "Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, Maeda H. Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 1999; 80: 1945\u20131954.", "journal-title": "Br J Cancer"}, {"key": "3_CR107", "first-page": "3567", "volume": "63", "author": "J Fang", "year": "2003", "unstructured": "Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, Hamada A, Maeda H. In vivo antitumor activity of pegylated zinc protoporphyrin: Targeted inhibition of heme oxygenase in solid tumor. Cancer Res 2003; 63: 3567\u20133574.", "journal-title": "Cancer Res"}, {"key": "3_CR108", "doi-asserted-by": "publisher", "first-page": "902", "DOI": "10.1038/sj.bjc.6600830", "volume": "88", "author": "S Tanaka", "year": "2003", "unstructured": "Tanaka S, Akaike T, Fang J, Beppu T, Ogawa M, Tamura F, Miyamoto Y, Maeda H. Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour. Br J Cancer 2003; 88: 902\u2013909.", "journal-title": "Br J Cancer"}, {"key": "3_CR109", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1023/B:APPT.0000012119.83734.4e", "volume": "9", "author": "J Fang", "year": "2004", "unstructured": "Fang J, Akaike T, Maeda H. Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis 2004; 9: 27\u201335.", "journal-title": "Apoptosis"}, {"key": "3_CR110", "doi-asserted-by": "publisher", "first-page": "1031", "DOI": "10.1021/bc020010k", "volume": "13", "author": "SK Sahoo", "year": "2002", "unstructured": "Sahoo SK, Sawa T, Fang J, Tanaka S, Miyamoto Y, Akaike T, Maeda H. Pegylated zinc protoporphyrin: A water-soluble heme oxygenase inhibitor with tumor-targeting capacity. Bioconjug Chem 2002; 13: 1031\u20131038.", "journal-title": "Bioconjug Chem"}, {"key": "3_CR111", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/ijc.11644", "volume": "109", "author": "J Fang", "year": "2004", "unstructured": "Fang J, Sawa T, Akaike T, Greish K, Maeda H. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer 2004; 109: 1\u20138.", "journal-title": "Int J Cancer"}, {"key": "3_CR112", "doi-asserted-by": "publisher", "first-page": "2200", "DOI": "10.1182/blood-2006-11-055723", "volume": "111", "author": "M Mayerhofer", "year": "2008", "unstructured": "Mayerhofer M, Gleixner KV, Mayerhofer J, Hoermann G, Jaeger E, Aichberger KJ, Ott RG, Greish K, Nakamura H, Derdak S, Samorapoompichit P, Pickl WF, Sexl V, Esterbauer H, Schwarzinger I, Sillaber C, Maeda H, Valent P. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood 2008; 111: 2200\u20132210.", "journal-title": "Blood"}, {"key": "3_CR113", "doi-asserted-by": "crossref", "first-page": "1461", "DOI": "10.1016/j.exphem.2008.06.002", "volume": "36", "author": "E Hadzijusufovic", "year": "2008", "unstructured": "Hadzijusufovic E, Rebuzzi L, Gleixner KV, Ferenc V, Peter B, Kondo R, Gruze A, Kneidinger M, Krauth MT, Mayerhofer M, Samorapoompichit P, Greish K, Iyer AK, Pickl WF, Maeda H, Willmann M, Valent P. Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis. Exp Hematol 2008; 36: 1461\u20131470.", "journal-title": "Exp Hematol"}, {"key": "3_CR114", "first-page": "14122", "volume": "25", "author": "KV Gleixner", "year": "2007", "unstructured": "Gleixner KV, Mayerhofer M, Vales A, Gruze A, Pickl WF, Lackner E, Sillaber C, Zielinski CC, Maeda H, Valent P. The Hsp32/HO-1-targeted drug SMA-ZnPP counteracts the proliferation and viability of neoplastic cells in solid tumors and hematologic neoplasms. J Clin Oncol 2007; 25: 14122.", "journal-title": "J Clin Oncol"}, {"key": "3_CR115", "doi-asserted-by": "publisher", "first-page": "494", "DOI": "10.1021/bc060158u", "volume": "18", "author": "M Regehly", "year": "2007", "unstructured": "Regehly M, Greish K, Rancan F, Maeda H, B\u00f6hm F, R\u00f6der B. Water-soluble polymer conjugates of ZnPP for photodynamic therapy. Bioconjug Chem 2007; 18: 494\u2013499.", "journal-title": "Bioconjug Chem"}, {"key": "3_CR116", "doi-asserted-by": "publisher", "first-page": "496", "DOI": "10.1080/10611860701498252", "volume": "15", "author": "AK Iyer", "year": "2007", "unstructured": "Iyer AK, Greish K, Seki T, Okazaki S, Fang J, Takeshita K, Maeda H. Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation. J Drug Target 2007; 15: 496\u2013506.", "journal-title": "J Drug Target"}, {"key": "3_CR117", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1111/j.1348-0421.1996.tb01129.x", "volume": "40", "author": "H Maeda", "year": "1996", "unstructured": "Maeda H. Role of microbial proteases in pathogenesis. Microbiol Immunol 1996; 40: 685\u2013699.", "journal-title": "Microbiol Immunol"}], "container-title": ["Pharmaceutical Perspectives of Cancer Therapeutics"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4419-0131-6_3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T10:17:17Z", "timestamp": 1556360237000}, "score": 27.618977, "issued": {"date-parts": [[2009]]}, "ISBN": ["9781441901309", "9781441901316"], "references-count": 117, "URL": "http://dx.doi.org/10.1007/978-1-4419-0131-6_3", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:38:21Z", "timestamp": 1574462301246}, "reference-count": 100, "publisher": "Japan Academy", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Proc. Jpn. Acad., Ser. B"], "published-print": {"date-parts": [[2012]]}, "DOI": "10.2183/pjab.88.53", "type": "journal-article", "created": {"date-parts": [[2012, 3, 22]], "date-time": "2012-03-22T18:41:57Z", "timestamp": 1332441717000}, "page": "53-71", "source": "Crossref", "is-referenced-by-count": 125, "title": ["Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting"], "prefix": "10.2183", "volume": "88", "author": [{"given": "Hiroshi", "family": "MAEDA", "sequence": "first", "affiliation": []}], "member": "993", "container-title": ["Proceedings of the Japan Academy, Series B"], "language": "en", "deposited": {"date-parts": [[2019, 6, 25]], "date-time": "2019-06-25T22:54:16Z", "timestamp": 1561503256000}, "score": 27.350498, "issued": {"date-parts": [[2012]]}, "references-count": 100, "journal-issue": {"published-print": {"date-parts": [[2012]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.2183/pjab.88.53", "ISSN": ["0386-2208", "1349-2896"], "issn-type": [{"value": "0386-2208", "type": "print"}, {"value": "1349-2896", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T02:49:13Z", "timestamp": 1574563753319}, "reference-count": 80, "publisher": "Informa Healthcare", "issue": "1", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Expert Opinion on Drug Delivery"], "published-print": {"date-parts": [[2015, 1, 2]]}, "DOI": "10.1517/17425247.2014.955011", "type": "journal-article", "created": {"date-parts": [[2014, 11, 26]], "date-time": "2014-11-26T11:53:01Z", "timestamp": 1417002781000}, "page": "53-64", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 95, "title": ["Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls"], "prefix": "10.1517", "volume": "12", "author": [{"given": "Hideaki", "family": "Nakamura", "sequence": "first", "affiliation": []}, {"given": "Fang", "family": "Jun", "sequence": "additional", "affiliation": []}, {"given": "Hiroshi", "family": "Maeda", "sequence": "additional", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2014, 11, 26]]}, "reference": [{"key": "CIT0001", "DOI": "10.1158/0008-5472.CAN-07-6611", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1126/science.103.2675.409", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "Macleod CM", "volume": "21", "first-page": "375", "year": "1945", "journal-title": "Bull N Y Acad Med"}, {"key": "CIT0004", "DOI": "10.1111/j.1399-3011.1979.tb01730.x", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1126/science.1241145", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1038/nm0596-561", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "author": "Deininger MW", "volume": "90", "first-page": "3691", "year": "1997", "journal-title": "Blood"}, {"key": "CIT0008", "DOI": "10.1200/JCO.2013.49.1845", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1016/j.ajpath.2013.07.005", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1016/j.tips.2013.11.004", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.3816/CLC.2009.n.004", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1634/theoncologist.12-7-864", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1002/cam4.106", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1126/science.1235122", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1038/nm1087", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.2183/pjab.88.53", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1111/j.1349-7006.1998.tb00563.x", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1016/j.jconrel.2011.09.063", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1111/cas.12152", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1016/S1567-5769(02)00271-0", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "author": "Matsumura Y", "volume": "46", "first-page": "6387", "year": "1986", "journal-title": "Cancer Res"}, {"key": "CIT0022", "DOI": "10.1016/S0169-409X(00)00134-4", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1016/j.jconrel.2012.04.038", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "author": "Yuan F", "volume": "55", "first-page": "3752", "year": "1995", "journal-title": "Cancer Res"}, {"key": "CIT0025", "DOI": "10.1016/S0002-9440(10)65006-7", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "author": "Iwai K", "volume": "44", "first-page": "2115", "year": "1984", "journal-title": "Cancer Res"}, {"key": "CIT0027", "DOI": "10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1016/0277-5379(83)90028-7", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.1002/1097-0142(19850815)56:4<751::AID-CNCR2820560409>3.0.CO;2-Y", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "DOI": "10.1093/jjco/hyp074", "doi-asserted-by": "publisher"}, {"key": "CIT0031", "DOI": "10.1016/0014-2964(73)90142-4", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "DOI": "10.1038/nbt1340", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1162/153535003765276237", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "author": "Maeda H", "year": "1986", "volume-title": "Cancer selective macromolecular therapeusis; tailoring of an antitumor protein drug"}, {"key": "CIT0035", "author": "Gabizon A", "volume": "54", "first-page": "987", "year": "1994", "journal-title": "Cancer Res"}, {"key": "CIT0036", "DOI": "10.1016/j.jconrel.2011.11.031", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "DOI": "10.1002/anie.200902672", "doi-asserted-by": "publisher"}, {"key": "CIT0038", "DOI": "10.1615/CritRevTherDrugCarrierSyst.v21.i5.20", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1016/j.nano.2009.04.008", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1016/j.addr.2009.11.028", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.1128/AAC.39.9.1954", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.1023/A:1018907715905", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "DOI": "10.1517/14712598.2014.900043", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "DOI": "10.1345/aph.1Q593", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "DOI": "10.1016/j.biomaterials.2010.01.065", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "DOI": "10.1164/ajrccm/140.4.1104", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1006/mvre.1994.1052", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "author": "Skinner SA", "volume": "50", "first-page": "2411", "year": "1990", "journal-title": "Cancer Res"}, {"key": "CIT0049", "DOI": "10.1111/j.1349-7006.1988.tb00050.x", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "author": "Suzuki M", "volume": "67", "first-page": "663", "year": "1981", "journal-title": "J Natl Cancer Inst"}, {"key": "CIT0051", "DOI": "10.1038/bjc.1993.179", "doi-asserted-by": "publisher"}, {"key": "CIT0052", "author": "Wu J", "volume": "58", "first-page": "159", "year": "1998", "journal-title": "Cancer Res"}, {"key": "CIT0053", "author": "Marketou ME", "volume": "53", "first-page": "91", "year": "2012", "journal-title": "Hellenic J Cardiol"}, {"key": "CIT0054", "DOI": "10.1111/j.1349-7006.1992.tb00093.x", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "DOI": "10.1111/j.1349-7006.2009.01323.x", "doi-asserted-by": "publisher"}, {"key": "CIT0056", "DOI": "10.1016/j.niox.2008.04.026", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "author": "Janssens MY", "volume": "58", "first-page": "5646", "year": "1998", "journal-title": "Cancer Res"}, {"key": "CIT0058", "DOI": "10.1200/JCO.2005.04.0436", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1016/S0006-291X(05)80832-0", "doi-asserted-by": "publisher"}, {"key": "CIT0060", "DOI": "10.1084/jem.169.6.1977", "doi-asserted-by": "publisher"}, {"key": "CIT0061", "author": "Ferrero E", "volume": "56", "first-page": "3211", "year": "1996", "journal-title": "Cancer Res"}, {"key": "CIT0062", "DOI": "10.1097/00000658-199612000-00011", "doi-asserted-by": "publisher"}, {"key": "CIT0063", "DOI": "10.1016/j.jconrel.2011.08.022", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "DOI": "10.1007/s10557-012-6400-6", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "DOI": "10.1016/j.phrs.2012.12.001", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "DOI": "10.1124/pr.107.07104", "doi-asserted-by": "publisher"}, {"key": "CIT0067", "DOI": "10.1023/B:APPT.0000012119.83734.4e", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "DOI": "10.1089/ars.2007.1659", "doi-asserted-by": "publisher"}, {"key": "CIT0069", "author": "Murphy BJ", "volume": "53", "first-page": "2700", "year": "1993", "journal-title": "Cancer Res"}, {"key": "CIT0070", "DOI": "10.1111/j.1349-7006.2011.02178.x", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "author": "Barth G", "volume": "88", "first-page": "1", "year": "1952", "journal-title": "Strahlentherapie"}, {"key": "CIT0072", "author": "Kong G", "volume": "60", "first-page": "4440", "year": "2000", "journal-title": "Cancer Res"}, {"key": "CIT0073", "author": "Kong G", "volume": "61", "first-page": "3027", "year": "2001", "journal-title": "Cancer Res"}, {"key": "CIT0074", "DOI": "10.1016/j.nucmedbio.2013.12.002", "doi-asserted-by": "publisher"}, {"key": "CIT0075", "DOI": "10.1016/j.jconrel.2012.05.019", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.1111/j.1349-7006.2010.01619.x", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "DOI": "10.1002/j.1552-4604.1996.tb04152.x", "doi-asserted-by": "publisher"}, {"key": "CIT0078", "DOI": "10.1016/j.addr.2012.09.038", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "DOI": "10.1016/j.jconrel.2011.12.012", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "DOI": "10.1111/cbdd.12085", "doi-asserted-by": "publisher"}], "container-title": ["Expert Opinion on Drug Delivery"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1517/17425247.2014.955011", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T16:19:43Z", "timestamp": 1481645983000}, "score": 25.667042, "issued": {"date-parts": [[2014, 11, 26]]}, "references-count": 80, "journal-issue": {"published-online": {"date-parts": [[2014, 8, 29]]}, "published-print": {"date-parts": [[2015, 1, 2]]}, "issue": "1"}, "alternative-id": ["10.1517/17425247.2014.955011"], "URL": "http://dx.doi.org/10.1517/17425247.2014.955011", "relation": {"cites": []}, "ISSN": ["1742-5247", "1744-7593"], "issn-type": [{"value": "1742-5247", "type": "print"}, {"value": "1744-7593", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iedd20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=iedd20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:41:18Z", "timestamp": 1575193278436}, "publisher-location": "Boston", "reference-count": 64, "publisher": "Kluwer Academic Publishers", "isbn-type": [{"value": "0306474719", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/0-306-47932-x_2", "type": "book-chapter", "created": {"date-parts": [[2005, 12, 11]], "date-time": "2005-12-11T00:23:53Z", "timestamp": 1134260633000}, "page": "29-49", "source": "Crossref", "is-referenced-by-count": 137, "title": ["Factors and Mechanism of \u201cEPR\u201d Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS"], "prefix": "10.1007", "author": [{"given": "Jun", "family": "Fang", "sequence": "first", "affiliation": []}, {"given": "Tomohiro", "family": "Sawa", "sequence": "additional", "affiliation": []}, {"given": "Hiroshi", "family": "Maeda", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "2_CR1", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1126/science.6823562", "volume": "219", "author": "D. R. Senger", "year": "1983", "unstructured": "Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F., 1983, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science\n                        219: 983\u2013985.", "journal-title": "Science"}, {"key": "2_CR2", "first-page": "5296", "volume": "55", "author": "M. Asano", "year": "1995", "unstructured": "Asano, M., Yukita, A., Matsumoto, T., Kondo, S., and Suzuki, H., 1995, Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor. Cancer Res.\n                        55: 5296\u20135301.", "journal-title": "Cancer Res."}, {"key": "2_CR3", "first-page": "193", "volume": "6", "author": "H. Maeda", "year": "1989", "unstructured": "Maeda, H., and Matsumura, Y., 1989, Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier Sys.\n                        6: 193\u2013210.", "journal-title": "Crit. Rev. Ther. Drug Carrier Sys."}, {"key": "2_CR4", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/0169-409X(91)90040-J", "volume": "6", "author": "H. Maeda", "year": "1991", "unstructured": "Maeda, H., 1991, SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev.\n                        6:181\u2013202.", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "2_CR5", "author": "H. Maeda", "first-page": "95", "year": "1994", "unstructured": "Maeda, H., 1994, Polymer conjugated macromolecular drugs for tumor-specific targeting. In Polymer Site Specific Pharmacotherapy (A. J. Domb, eds.) John Wiley & Sons Ltd., New York, USA, pp. 95\u2013116.", "volume-title": "Polymer Site Specific Pharmacotherapy"}, {"key": "2_CR6", "doi-asserted-by": "publisher", "first-page": "351", "DOI": "10.1021/bc00017a001", "volume": "3", "author": "H. Maeda", "year": "1992", "unstructured": "Maeda, H., Seymour, L., and Miyamoto, Y., 1992, Conjugation of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjugate Chem.\n                        3: 351\u2013362.", "journal-title": "Bioconjugate Chem."}, {"key": "2_CR7", "author": "F. C. Courtice", "first-page": "89", "year": "1963", "unstructured": "Courtice, F. C., 1963, The origin of lipoprotein. In Lymph and Lymphatic System (H. S. Meyersen, Chairman) Charles C. Thomas, Springfield, IL, USA, pp. 89\u2013126.", "volume-title": "Lymph and Lymphatic System"}, {"key": "2_CR8", "first-page": "7", "volume": "5", "author": "F. M. Muggia", "year": "1999", "unstructured": "Muggia, F. M., 1999, Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention. Clin. Cancer Res.\n                        5: 7\u20138.", "journal-title": "Clin. Cancer Res."}, {"key": "2_CR9", "doi-asserted-by": "publisher", "first-page": "1182", "DOI": "10.1056/NEJM197108122850711", "volume": "285", "author": "J. Folkman", "year": "1971", "unstructured": "Folkman, J., 1971, Tumor angiogenesis: therapeutic implications. N. Engl. J. Med.\n                        285: 1182\u20131186.", "journal-title": "N. Engl. J. Med."}, {"key": "2_CR10", "first-page": "10931", "volume": "267", "author": "J. Folkman", "year": "1992", "unstructured": "Folkman, J., and Shing, Y., 1992, Angiogenesis, J. Biol. Chem.\n                        267: 10931\u201310934.", "journal-title": "J. Biol. Chem."}, {"key": "2_CR11", "first-page": "16051", "volume": "263", "author": "H. Maeda", "year": "1988", "unstructured": "Maeda, H., Matsumura, Y., and Kato, H., 1988, Purification and identification of [hydroxyprolyl 3] bradykinin in ascitic fluid from a patient with gastric cancer. J. Biol. Chem.\n                        263: 16051\u201316054.", "journal-title": "J. Biol. Chem."}, {"key": "2_CR12", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.1111/j.1349-7006.1988.tb01563.x", "volume": "79", "author": "Y. Matsumura", "year": "1988", "unstructured": "Matsumura, Y., Kimura, M., Yamamoto, T., and Maeda, H., 1988, Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn. J. Cancer Res.\n                        79: 1327\u20131334.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "2_CR13", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1111/j.1349-7006.1991.tb01910.x", "volume": "82", "author": "Y. Matsumura", "year": "1991", "unstructured": "Matsumura, Y., Maruo, K., Kimura, M., Yamamoto, T., Konno, T., and Maeda, H., 1991, Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn. J. Cancer Res.\n                        82: 732\u2013741.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "2_CR14", "first-page": "159", "volume": "58", "author": "J. Wu", "year": "1998", "unstructured": "Wu, J., Akaike, T., and Maeda, H., 1998, Modulation of enhanced vascular permeability in tumors by bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res.\n                        58: 159\u2013165.", "journal-title": "Cancer Res."}, {"key": "2_CR15", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1111/j.1349-7006.1994.tb02362.x", "volume": "85", "author": "H. Maeda", "year": "1994", "unstructured": "Maeda, H., Noguchi, Y., Sato, K., and Akaike, T., 1994, Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res.\n                        85: 331\u2013334.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "2_CR16", "doi-asserted-by": "crossref", "first-page": "1598", "DOI": "10.1002/(SICI)1097-0142(19960415)77:8<1598::AID-CNCR27>3.0.CO;2-U", "volume": "77", "author": "K. Doi", "year": "1996", "unstructured": "Doi, K., Akaike, T., Horie, M., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M., and Maeda, H., 1996, Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer\n                        77: 1598\u20131604.", "journal-title": "Cancer"}, {"key": "2_CR17", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1016/0006-291X(89)92678-8", "volume": "161", "author": "N. Ferratra", "year": "1989", "unstructured": "Ferratra, N., and Henzel, W. J., 1989, Pituitary follicular cells secrete a novel heparinbinding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun.\n                        161: 851\u2013858.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "2_CR18", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.3109/08977199009011010", "volume": "4", "author": "R. A. Rosenthal", "year": "1990", "unstructured": "Rosenthal, R. A., Megyesi, J. F., Henzel, W. J., Ferrara, N., and Folkman, J., 1990, Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors\n                        4: 53\u201359.", "journal-title": "Growth Factors"}, {"key": "2_CR19", "doi-asserted-by": "crossref", "first-page": "1306", "DOI": "10.1126/science.2479986", "volume": "246", "author": "D. W. Leung", "year": "1989", "unstructured": "Leung, D. W., Cachianes, G., Kuang. W-J., Goeddel, D. V., and Ferrara, N., 1989, Vascular endothelial growth factor is a secreted angiogenic mitogen. Science\n                        246: 1306\u20131309.", "journal-title": "Science"}, {"key": "2_CR20", "doi-asserted-by": "crossref", "first-page": "1309", "DOI": "10.1126/science.2479987", "volume": "246", "author": "P. J. Keck", "year": "1989", "unstructured": "Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T., 1989, Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science\n                        246: 1309\u20131312.", "journal-title": "Science"}, {"key": "2_CR21", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.3171/jns.1986.65.2.0233", "volume": "65", "author": "H. R. Reichman", "year": "1986", "unstructured": "Reichman, H. R., Farrell, C. L, and Del Maestro, F. R., 1986, Effect of steroids and nonsteroid anti-inflammatory agents on vascular permeability in a rat glioma model. J. Neurosurg.\n                        65: 233\u2013237.", "journal-title": "J. Neurosurg."}, {"key": "2_CR22", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1111/j.1349-7006.2001.tb01114.x", "volume": "92", "author": "J. Wu", "year": "2001", "unstructured": "Wu, J., Akaike, T., Hayashida, K., Okamoto, T., Okuyama, A., and Maeda, H., 2001, Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn. J. Cancer Res.\n                        92: 439\u2013451.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "2_CR23", "doi-asserted-by": "crossref", "first-page": "444", "DOI": "10.1002/1097-0142(19870201)59:3<444::AID-CNCR2820590316>3.0.CO;2-5", "volume": "59", "author": "M. Suzuki", "year": "1987", "unstructured": "Suzuki, M., Takahashi, T., and Sato, T., 1987, Medial regression and its functional significance in tumor-supplying host arteries. Cancer\n                        59: 444\u2013450.", "journal-title": "Cancer"}, {"key": "2_CR24", "first-page": "2411", "volume": "50", "author": "S. A. Skinner", "year": "1991", "unstructured": "Skinner, S. A., Tutton, P. J. M., and O\u2019Brien, E., 1991, Microvascular architecture of experimental colon tumors in the rats. Cancer Res.\n                        50: 2411\u20132417.", "journal-title": "Cancer Res."}, {"key": "2_CR25", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1006/jsre.2001.6299", "volume": "103", "author": "D. Kuruppu", "year": "2002", "unstructured": "Kuruppu, D., Christophi, C., Maeda, H., and O\u2019Brien, P. E., 2002, Changes in the microvascular architecture of colorectal liver metastases following the administration of SMANCS/lipiodol. J. Surg. Res.\n                        103: 47\u201354.", "journal-title": "J. Surg. Res."}, {"key": "2_CR26", "first-page": "6387", "volume": "46", "author": "Y. Matsumura", "year": "1986", "unstructured": "Matsumura, Y., and Maeda, H., 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res.\n                        46: 6387\u20136392.", "journal-title": "Cancer Res."}, {"key": "2_CR27", "first-page": "2115", "volume": "44", "author": "K. Iwai", "year": "1984", "unstructured": "Iwai, K., Maeda, H., and Konno, T., 1984, Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res.\n                        44: 2115\u20132121.", "journal-title": "Cancer Res."}, {"key": "2_CR28", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1111/j.1349-7006.1998.tb00563.x", "volume": "89", "author": "Y. Noguchi", "year": "1998", "unstructured": "Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., and Maeda, H., 1998, Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res.\n                        89: 307\u2013314.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "2_CR29", "first-page": "321", "volume": "7", "author": "K. Iwai", "year": "1987", "unstructured": "Iwai, K., Maeda, H., Konno, T., Matsumura, Y., Yamashita, R., Yamasaki, K., Hirayama, S., and Miyauchi, Y., 1987, Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver. Anticancer Res.\n                        7: 321\u2013328.", "journal-title": "Anticancer Res."}, {"key": "2_CR30", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1007/BF01040499", "volume": "3", "author": "H. Maeda", "year": "1984", "unstructured": "Maeda, H., Matsumoto, T., Konno, T., Iwai, K., and Ueda, M., 1984, Tailor-making of protein drugs by polymer conjugation for tumor targeting: a brief review on Smancs. J. Prot. Chem.\n                        3: 181\u2013193.", "journal-title": "J. Prot. Chem."}, {"key": "2_CR31", "author": "H. Maeda", "first-page": "353", "year": "1986", "unstructured": "Maeda, H., Matsumura, Y., Oda, T., and Sasamoto, K., 1986, Cancer selective macromolecular therapeutics: tailoring of antitumor protein drugs. In Protein Tailoring. for Food and Medical Uses (R. E. Feeney and J. R. Whitaker, eds.) Marcel Dekker Inc., New York, USA, pp. 353\u2013382.", "volume-title": "Protein Tailoring. for Food and Medical Uses"}, {"key": "2_CR32", "author": "T. Sawa", "year": "2002", "unstructured": "Sawa, T., Sahoo, S. K., and Maeda H., 2002, Water-soluble polymer therapeutics with special emphasis on cancer chemotherapy. In Polymers in Medicine and Biotechnology (Ashady, eds.), Am. Chem. Soc., Washington D. C., Monograph, in press.", "volume-title": "Polymers in Medicine and Biotechnology"}, {"key": "2_CR33", "first-page": "663", "volume": "67", "author": "M. Suzuki", "year": "1981", "unstructured": "Suzuki, M., Hori, K., Abe, Z., Saito, S., and Sato, H., 1981, A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J. Natl. Cancer Inst.\n                        67: 663\u2013669.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "2_CR34", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1038/bjc.1993.179", "volume": "67", "author": "C. J. Li", "year": "1993", "unstructured": "Li, C. J., Miyamoto, Y., Kojima, Y., and Maeda, H., 1993, Augmentation of tumor delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure. Br. J. Cancer\n                        67: 975\u2013980.", "journal-title": "Br. J. Cancer"}, {"key": "2_CR35", "first-page": "217", "volume": "377", "author": "H. Maeda", "year": "1996", "unstructured": "Maeda, H., and Yamamoto, T., 1996, Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol. Chem. Hoppe-Seyler.\n                        377: 217\u2013226.", "journal-title": "Biol. Chem. Hoppe-Seyler."}, {"key": "2_CR36", "first-page": "4027", "volume": "56", "author": "S. Nakano", "year": "1996", "unstructured": "Nakano, S., Mastukado, K., and Black, K. L., 1996, Increased brain tumor microvessel permeability after intracarotid bradkinin infusion is mediated by nitric oxide. Cancer Res.\n                        56: 4027\u20134031.", "journal-title": "Cancer Res."}, {"key": "2_CR37", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1111/j.1476-5381.1993.tb13525.x", "volume": "109", "author": "D. E. Hu", "year": "1993", "unstructured": "Hu, D. E., and Fan, T. P., 1993, [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats. Br. J. Pharmacol.\n                        109: 14\u201317.", "journal-title": "Br. J. Pharmacol."}, {"key": "2_CR38", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/S0162-3109(99)00104-6", "volume": "43", "author": "H. Maeda", "year": "1999", "unstructured": "Maeda, H., Wu, J., Okamoto, T., Maruo, K., and Akaike, T., 1999, Kallikrein-kinin in infection and cancer. Immunopharmacology.\n                        43: 115\u2013128.", "journal-title": "Immunopharmacology."}, {"key": "2_CR39", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1111/j.1349-7006.2000.tb00940.x", "volume": "91", "author": "K. Hori", "year": "2000", "unstructured": "Hori, K., Saito, S., Takahashi, H., Sato, H., Maeda, H., and Sato, Y., 2000, Tumorselective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride. Jpn. J. Cancer Res.\n                        91: 261\u2013269.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "2_CR40", "doi-asserted-by": "crossref", "first-page": "724", "DOI": "10.1002/ijc.2910150503", "volume": "15", "author": "H. R. Strausser", "year": "1975", "unstructured": "Strausser, H. R., and Humes, J. L., 1975, Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in BALB/c mice. Int. J. Cancer\n                        15: 724\u2013730.", "journal-title": "Int. J. Cancer"}, {"key": "2_CR41", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1038/bjc.1980.56", "volume": "41", "author": "A. Trevisani", "year": "1980", "unstructured": "Trevisani, A., Ferretti, E., Capuzzo, A., and Tomasi, V., 1980, Elevated levels of prostaglandin E\n                        2 in Yoshida hepatoma and the inhibition of tumor growth by nonsteroidal anti-inflammatory drugs. Br. J. Cancer\n                        41: 341\u2013347.", "journal-title": "Br. J. Cancer"}, {"key": "2_CR42", "doi-asserted-by": "crossref", "first-page": "912", "DOI": "10.1093/jnci/85.11.912", "volume": "85", "author": "E. R. Greengberg", "year": "1993", "unstructured": "Greengberg, E. R., Baron, J. A., Freeman, D. H., Mandel, J. S. Jr, and Haile, R., 1993, Reduced risk of large-bowel adenomas among aspirin users. J. Natl. Cancer Inst.\n                        85: 912\u2013916.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "2_CR43", "doi-asserted-by": "crossref", "first-page": "1169", "DOI": "10.1038/bjc.1995.228", "volume": "71", "author": "R. E. Meyer", "year": "1995", "unstructured": "Meyer, R. E., Shan, S., Deangelo, J., Dodge, R. K., Bonaventura, J., Ong. E. T., and Dewhirst, M. W., 1995, Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br. J. Cancer\n                        71: 1169\u20131174.", "journal-title": "Br. J. Cancer"}, {"key": "2_CR44", "first-page": "948", "volume": "57", "author": "G. M. Tozer", "year": "1997", "unstructured": "Tozer, G. M., Prise, V. E., and Chaplin, D. J., 1997, Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine, Cancer Res.\n                        57: 948\u2013955.", "journal-title": "Cancer Res."}, {"key": "2_CR45", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1093/jnci/90.8.587", "volume": "90", "author": "O. Gallo", "year": "1998", "unstructured": "Gallo, O., Masini, E., Morbidelli, L., Franchi, A., Fini-Storchi, I., Vergari, W. A., and Ziche, M., 1998, Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst.\n                        90: 587\u2013596.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "2_CR46", "doi-asserted-by": "publisher", "first-page": "560", "DOI": "10.1093/jnci/90.8.560", "volume": "90", "author": "G. Garcia-Cardena", "year": "1998", "unstructured": "Garcia-Cardena, G., and Folkman, J., 1998, Is there a role for nitric oxide in tumor angiogenesis. (Editorial) J. Natl Cancer Inst.\n                        90: 560\u2013561.", "journal-title": "J. Natl Cancer Inst."}, {"key": "2_CR47", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1096/fasebj.11.6.9194526", "volume": "11", "author": "J. R. Jackson", "year": "1997", "unstructured": "Jackson, J. R., Seed, M. P., Kirchen, C. H., Willoughby, D. A., and Winkler, J. D., 1997, The codependence of angiogenesis and chronic inflammation. FASEB J.\n                        11: 457\u2013465.", "journal-title": "FASEB J."}, {"key": "2_CR48", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1111/j.1399-3011.1979.tb01730.x", "volume": "14", "author": "H. Maeda", "year": "1979", "unstructured": "Maeda, H., Takishita, J., and Kanamaru, R., 1979, A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic. Int. J. Pept. Protein Res.\n                        14: 81\u201387.", "journal-title": "Int. J. Pept. Protein Res."}, {"key": "2_CR49", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1021/jm00382a012", "volume": "28", "author": "H. Maeda", "year": "1985", "unstructured": "Maeda, H., Ueda, M., Morinaga, T., and Matsumoto, T., 1985, Conjugation of poly(styrene-co-maleic acid) derivatives to antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties. J. Med. Chem.\n                        28: 455\u2013461.", "journal-title": "J. Med. Chem."}, {"key": "2_CR50", "doi-asserted-by": "crossref", "first-page": "2367", "DOI": "10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F", "volume": "54", "author": "T. Konno", "year": "1984", "unstructured": "Konno, T., Maeda, H., Iwai K., Maki, S., Tashiro, S., Uchida, M., and Miyauchi, Y., 1984, Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer\n                        54: 2367\u20132374.", "journal-title": "Cancer"}, {"key": "2_CR51", "doi-asserted-by": "publisher", "first-page": "1053", "DOI": "10.1016/0277-5379(83)90028-7", "volume": "19", "author": "T. Konno", "year": "1983", "unstructured": "Konno, T., Maeda, H., Iwai, K., Tashiro, S., Maki, S., Marinaga, T., Mochinaga, M., Hiraoka, T., and Yokoyama, I., 1983, Effect of arterial administration of highmolecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur. J. Cancer Clin. Oncol.\n                        19: 1053\u20131065.", "journal-title": "Eur. J. Cancer Clin. Oncol."}, {"key": "2_CR52", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1002/1097-0142(19850815)56:4<751::AID-CNCR2820560409>3.0.CO;2-Y", "volume": "56", "author": "S. Maki", "year": "1985", "unstructured": "Maki, S., Konno, T., and Maeda, H., 1985, Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer\n                        56: 751\u2013757.", "journal-title": "Cancer"}, {"key": "2_CR53", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1016/S0090-4295(99)00537-3", "volume": "55", "author": "K. Tsuchikya", "year": "2000", "unstructured": "Tsuchikya, K., Uchida, T., Kobayashi, M., Maeda, H., Konno, T., and Yamanaka, H., 2000, Tumor-targeted chemotherapy with SMANCS in Lipiodol for renal cell carcinoma: longer survival with larger size tumors. Urology\n                        55: 495\u2013500.", "journal-title": "Urology"}, {"key": "2_CR54", "author": "H. Maeda", "first-page": "221", "year": "1994", "unstructured": "Maeda, H., and Miyamoto, Y., 1994, SMANCS approach \u2014 Oily formulation of protein drugs for arterial injection and oral administration. In Drug Absorption Enhancement: Concepts, Possibilities, Limitations, and Trends (A. G. De Boer, ed.) Harwood Academic Publishers, Chur, Switzerland, pp. 221\u2013247.", "volume-title": "Drug Absorption Enhancement: Concepts, Possibilities, Limitations, and Trends"}, {"key": "2_CR55", "author": "T. Konno", "first-page": "343", "year": "1987", "unstructured": "Konno, T., and Maeda, H., 1987, Targeting chemotherapy of hepatocellular carcinoma: arterial administration of SMANCS/Lipiodol. In Neoplasms of the Liver (K. Okuda, K.G. Ishak, eds.), Springer-Verlag, Tokyo, Berlin, New York, pp. 343\u2013352.", "volume-title": "Neoplasms of the Liver", "DOI": "10.1007/978-4-431-68349-0_27", "doi-asserted-by": "crossref"}, {"key": "2_CR56", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1016/S0959-8049(05)80063-2", "volume": "28", "author": "T. Konno", "year": "1992", "unstructured": "Konno, T., 1992, Targeting chemotherapy for hepatoma: arterial administration of anticancer drugs dissolved in Lipiodol. Eur. J. Cancer\n                        28: 403\u2013409.", "journal-title": "Eur. J. Cancer"}, {"key": "2_CR57", "author": "H. Maeda", "first-page": "227", "year": "1997", "unstructured": "Maeda, H., and Konno, T., 1997, Metamorphosis of neocarzinostatin to SMANCS: chemistry, biology, pharmacology and clinical effect of the first prototype anticancer polymer therapeutic. In Neocarzinostatin: The Past, Present, and Future of an Anticancer Drug (H. Maeda, K. Edo and N. Ishida, eds.) Springer-Verlag, Tokyo, Berlin, New York, pp. 227\u2013267.", "volume-title": "Neocarzinostatin: The Past, Present, and Future of an Anticancer Drug", "DOI": "10.1007/978-4-431-66914-2_12", "doi-asserted-by": "crossref"}, {"key": "2_CR58", "first-page": "666", "volume": "60", "author": "T. Sawa", "year": "2000", "unstructured": "Sawa, T., Wu, J., Akaike, T. and Maeda H., 2000, Tumor-targeting chemotherapy by a xanthine oxidase-polymer conjugate that generates oxygen-free radicals in tumor tissue. Cancer Res.\n                        60: 666\u2013671.", "journal-title": "Cancer Res."}, {"key": "2_CR59", "first-page": "3138", "volume": "62", "author": "J. Fang", "year": "2002", "unstructured": "Fang, J., Sawa, T., Akaike, T., and Maeda, H., 2002, Tumor-Targeted Delivery of PEGConjugated D-Amino Acid Oxidase for Antitumor Therapy via Enzymatic Generation of Hydrogen Peroxide. Cancer Res.\n                        62: 3138\u20133143.", "journal-title": "Cancer Res."}, {"key": "2_CR60", "doi-asserted-by": "publisher", "first-page": "1031", "DOI": "10.1021/bc020010k", "volume": "13", "author": "S. K. Sahoo", "year": "2002", "unstructured": "Sahoo, S. K., Sawa, T., Fang, J., Tanaka, S., Miyamoto, Y., Akaike, T., and Maeda H., 2002, Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity. Bioconjug. Chem.\n                        13: 1031\u20131038.", "journal-title": "Bioconjug. Chem."}, {"key": "2_CR61", "doi-asserted-by": "publisher", "first-page": "1945", "DOI": "10.1038/sj.bjc.6690624", "volume": "80", "author": "K. Doi", "year": "1999", "unstructured": "Doi, K., Akaike, T., Fujii, S., Tanaka, S., Ikebe, S., Beppu, N., Shibahara, T., Ogawa, S., and Maeda, H., 1999, Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br. J. Cancer\n                        80: 1945\u20131954.", "journal-title": "Br. J. Cancer"}, {"key": "2_CR62", "unstructured": "Tanaka, S., Akaike, T., Fang, J., Beppu, T., Ogawa, M., Tamura, F., Miyamoto, Y., and Maeda, H., 2002, Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour. Br. J. Cancer (in press)."}, {"key": "2_CR63", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1016/S0168-3659(01)00309-1", "volume": "74", "author": "H. Maeda", "year": "2001", "unstructured": "Maeda, H., Sawa, T., and Konno, T., 2001, Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Controlled Release\n                        74: 47\u201361.", "journal-title": "J. Controlled Release"}, {"key": "2_CR64", "author": "H. Maeda", "year": "2002", "unstructured": "Maeda, H., 2002, Enhanced permeability and Retention (EPR) Effect: Basis for Drug Targeting to Tumor. In Biomedical Aspects of Drug Targeting (V. Muzykantov and V. Torchilin, eds.), Kluwer Academic Publishers, Dordrecht.", "volume-title": "Biomedical Aspects of Drug Targeting"}], "container-title": ["Advances in Experimental Medicine and Biology", "Polymer Drugs in the Clinical Stage"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/0-306-47932-X_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 6]], "date-time": "2019-02-06T18:41:25Z", "timestamp": 1549478485000}, "score": 25.667042, "issued": {"date-parts": [[null]]}, "ISBN": ["0306474719"], "references-count": 64, "URL": "http://dx.doi.org/10.1007/0-306-47932-x_2", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:17:25Z", "timestamp": 1574536645892}, "reference-count": 20, "publisher": "Future Science Ltd", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Therapeutic Delivery"], "published-print": {"date-parts": [[2014, 6]]}, "DOI": "10.4155/tde.14.36", "type": "journal-article", "created": {"date-parts": [[2014, 8, 4]], "date-time": "2014-08-04T15:27:43Z", "timestamp": 1407166063000}, "page": "627-630", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Research Spotlight: Emergence of EPR effect theory and development of clinical applications for cancer therapy"], "prefix": "10.4155", "volume": "5", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}], "member": "2641", "reference": [{"key": "B1", "DOI": "10.1007/978-4-431-66914-2_12", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1002/0471203076.emm0368", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1126/science.2543070", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1073/pnas.93.6.2448", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1111/j.1349-7006.1991.tb01910.x", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1111/cas.12152", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1016/0169-409X(91)90040-J", "doi-asserted-by": "publisher"}, {"key": "B8", "author": "Matsumura Y", "volume": "46", "first-page": "6387", "year": "1986", "journal-title": "Cancer Res."}, {"key": "B9", "DOI": "10.1016/0014-2964(80)90215-7", "doi-asserted-by": "publisher"}, {"key": "B10", "author": "Maeda H", "volume": "70", "first-page": "601", "year": "1979", "journal-title": "Gann"}, {"key": "B11", "author": "Maeda H", "volume": "6", "first-page": "193", "year": "1989", "journal-title": "Crit. Rev. Ther. Drug Carrier Syst."}, {"key": "B12", "DOI": "10.1111/j.1349-7006.2010.01619.x", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1002/1097-0142(19870501)59:9<1560::AID-CNCR2820590905>3.0.CO;2-J", "doi-asserted-by": "publisher"}, {"key": "B14", "author": "Iwai K", "volume": "44", "first-page": "2115", "year": "1984", "journal-title": "Cancer Res."}, {"key": "B15", "DOI": "10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO;2-F", "doi-asserted-by": "publisher"}, {"key": "B16", "DOI": "10.1093/jjco/hyp074", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1023/A:1015917000556", "doi-asserted-by": "publisher"}, {"key": "B18", "DOI": "10.1016/j.jconrel.2012.04.038", "doi-asserted-by": "publisher"}, {"key": "B19", "DOI": "10.1200/JCO.2005.04.0436", "doi-asserted-by": "publisher"}, {"key": "B20", "author": "Gomer CJ", "volume": "50", "first-page": "3985", "year": "1990", "journal-title": "Cancer Res."}], "container-title": ["Therapeutic Delivery"], "language": "en", "link": [{"URL": "http://www.future-science.com/doi/pdf/10.4155/tde.14.36", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:55:55Z", "timestamp": 1574243755000}, "score": 25.22181, "issued": {"date-parts": [[2014, 6]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2014, 6]]}, "issue": "6"}, "alternative-id": ["10.4155/tde.14.36"], "URL": "http://dx.doi.org/10.4155/tde.14.36", "relation": {"cites": []}, "ISSN": ["2041-5990", "2041-6008"], "issn-type": [{"value": "2041-5990", "type": "print"}, {"value": "2041-6008", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T13:21:10Z", "timestamp": 1574428870798}, "reference-count": 9, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 3, 1]], "date-time": "2011-03-01T00:00:00Z", "timestamp": 1298937600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advanced Drug Delivery Reviews"], "published-print": {"date-parts": [[2011, 3]]}, "DOI": "10.1016/j.addr.2010.05.001", "type": "journal-article", "created": {"date-parts": [[2010, 5, 11]], "date-time": "2010-05-11T08:35:03Z", "timestamp": 1273566903000}, "page": "129-130", "source": "Crossref", "is-referenced-by-count": 127, "title": ["EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy"], "prefix": "10.1016", "volume": "63", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}, {"given": "Yasuhiro", "family": "Matsumura", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Advanced Drug Delivery Reviews"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169409X10000931?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169409X10000931?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 11]], "date-time": "2018-12-11T08:00:09Z", "timestamp": 1544515209000}, "score": 24.2714, "issued": {"date-parts": [[2011, 3]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2011, 3]]}, "issue": "3"}, "alternative-id": ["S0169409X10000931"], "URL": "http://dx.doi.org/10.1016/j.addr.2010.05.001", "ISSN": ["0169-409X"], "issn-type": [{"value": "0169-409X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:54:30Z", "timestamp": 1574463270407}, "reference-count": 1, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1837, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemInform"], "DOI": "10.1002/chin.199303321", "type": "journal-article", "created": {"date-parts": [[2010, 9, 8]], "date-time": "2010-09-08T17:09:28Z", "timestamp": 1283965768000}, "page": "no-no", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: Conjugates of Anticancer Agents and Polymers: Advantages of Macromolecular Therapeutics in vivo"], "prefix": "10.1002", "volume": "24", "author": [{"given": "H.", "family": "MAEDA", "sequence": "first", "affiliation": []}, {"given": "L. W.", "family": "SEYMOUR", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "MIYAMOTO", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 8, 21]]}, "reference": [{"key": "10.1002/chin.199303321-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1021/bc00017a001", "article-title": "Conjugates of Anticancer Agents and Polymers: Advantages of Macromolecular Therapeutics in vivo", "volume": "3", "author": "MAEDA", "year": "1992", "journal-title": "Bioconjugate Chem."}], "container-title": ["ChemInform"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.199303321", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.199303321", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 4]], "date-time": "2019-03-04T10:18:15Z", "timestamp": 1551694695000}, "score": 23.218798, "issued": {"date-parts": [[2010, 8, 21]]}, "references-count": 1, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1002/chin.199303321", "relation": {"cites": []}, "ISSN": ["0931-7597"], "issn-type": [{"value": "0931-7597", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T16:39:29Z", "timestamp": 1574267969647}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Cancer Therapeutics"], "published-print": {"date-parts": [[2007, 1, 1]]}, "DOI": "10.1158/1535-7163.mct-06-0529", "type": "journal-article", "created": {"date-parts": [[2007, 1, 19]], "date-time": "2007-01-19T17:58:15Z", "timestamp": 1169229495000}, "page": "122-127", "source": "Crossref", "is-referenced-by-count": 64, "title": ["MRP8/ABCC11 directly confers resistance to 5-fluorouracil"], "prefix": "10.1158", "volume": "6", "author": [{"given": "T.", "family": "Oguri", "sequence": "first", "affiliation": []}, {"given": "Y.", "family": "Bessho", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Achiwa", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Ozasa", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Maeno", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Maeda", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Sato", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Ueda", "sequence": "additional", "affiliation": []}], "member": "1086", "container-title": ["Molecular Cancer Therapeutics"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1535-7163.MCT-06-0529", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T08:22:50Z", "timestamp": 1482481370000}, "score": 22.547657, "issued": {"date-parts": [[2007, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1158/1535-7163.mct-06-0529", "ISSN": ["1535-7163", "1538-8514"], "issn-type": [{"value": "1535-7163", "type": "print"}, {"value": "1538-8514", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:35:55Z", "timestamp": 1574145355820}, "reference-count": 66, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1991, 3, 1]], "date-time": "1991-03-01T00:00:00Z", "timestamp": 667785600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advanced Drug Delivery Reviews"], "published-print": {"date-parts": [[1991, 3]]}, "DOI": "10.1016/0169-409x(91)90040-j", "type": "journal-article", "created": {"date-parts": [[2002, 12, 13]], "date-time": "2002-12-13T22:04:39Z", "timestamp": 1039817079000}, "page": "181-202", "source": "Crossref", "is-referenced-by-count": 163, "title": ["SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy"], "prefix": "10.1016", "volume": "6", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Advanced Drug Delivery Reviews"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0169409X9190040J?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0169409X9190040J?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T04:21:52Z", "timestamp": 1554178912000}, "score": 22.30083, "issued": {"date-parts": [[1991, 3]]}, "references-count": 66, "journal-issue": {"published-print": {"date-parts": [[1991, 3]]}, "issue": "2"}, "alternative-id": ["0169409X9190040J"], "URL": "http://dx.doi.org/10.1016/0169-409x(91)90040-j", "ISSN": ["0169-409X"], "issn-type": [{"value": "0169-409X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:42:42Z", "timestamp": 1574415762063}, "reference-count": 0, "publisher": "PUBLISHED BY IMPERIAL COLLEGE PRESS AND DISTRIBUTED BY WORLD SCIENTIFIC PUBLISHING CO.", "isbn-type": [{"value": "9781860946271", "type": "print"}, {"value": "9781860948039", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006, 4]]}, "DOI": "10.1142/9781860948039_0003", "type": "book-chapter", "created": {"date-parts": [[2010, 3, 4]], "date-time": "2010-03-04T05:55:58Z", "timestamp": 1267682158000}, "page": "37-52", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Enhanced Permeability and Retention (EPR) Effect and Tumor-Selective Delivery of Anticancer Drugs"], "prefix": "10.1142", "author": [{"given": "K.", "family": "Greish", "sequence": "first", "affiliation": [{"name": "Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1, Ikeda, Kumamoto, 860-0082, Japan"}]}, {"given": "A. K.", "family": "Iyer", "sequence": "additional", "affiliation": [{"name": "Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1, Ikeda, Kumamoto, 860-0082, Japan"}]}, {"given": "J.", "family": "Fang", "sequence": "additional", "affiliation": [{"name": "Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1, Ikeda, Kumamoto, 860-0082, Japan"}]}, {"given": "M.", "family": "Kawasuji", "sequence": "additional", "affiliation": [{"name": "Department of Cardiovascular Surgery, Kumamoto University, Graduate School of Medical Sciences, Honjo 1-1-1, Kumamoto, Japan"}]}, {"given": "H.", "family": "Maeda", "sequence": "additional", "affiliation": [{"name": "Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1, Ikeda, Kumamoto, 860-0082, Japan"}]}], "member": "219", "published-online": {"date-parts": [[2012, 1, 26]]}, "container-title": ["Delivery of Protein and Peptide Drugs in Cancer"], "deposited": {"date-parts": [[2017, 7, 19]], "date-time": "2017-07-19T20:41:23Z", "timestamp": 1500496883000}, "score": 22.227474, "issued": {"date-parts": [[2006, 4]]}, "ISBN": ["9781860946271", "9781860948039"], "references-count": 0, "alternative-id": ["10.1142/9781860948039_0003", "10.1142/p429"], "URL": "http://dx.doi.org/10.1142/9781860948039_0003"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T16:15:41Z", "timestamp": 1574266541999}, "reference-count": 122, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 3, 1]], "date-time": "2009-03-01T00:00:00Z", "timestamp": 1235865600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmaceutics and Biopharmaceutics"], "published-print": {"date-parts": [[2009, 3]]}, "DOI": "10.1016/j.ejpb.2008.11.010", "type": "journal-article", "created": {"date-parts": [[2008, 12, 5]], "date-time": "2008-12-05T17:40:37Z", "timestamp": 1228498837000}, "page": "409-419", "source": "Crossref", "is-referenced-by-count": 733, "title": ["Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect"], "prefix": "10.1016", "volume": "71", "author": [{"given": "H.", "family": "Maeda", "sequence": "first", "affiliation": []}, {"given": "G.Y.", "family": "Bharate", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Daruwalla", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmaceutics and Biopharmaceutics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0939641108004505?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0939641108004505?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 16]], "date-time": "2019-05-16T01:10:52Z", "timestamp": 1557969052000}, "score": 21.943764, "issued": {"date-parts": [[2009, 3]]}, "references-count": 122, "journal-issue": {"published-print": {"date-parts": [[2009, 3]]}, "issue": "3"}, "alternative-id": ["S0939641108004505"], "URL": "http://dx.doi.org/10.1016/j.ejpb.2008.11.010", "ISSN": ["0939-6411"], "issn-type": [{"value": "0939-6411", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:47:02Z", "timestamp": 1574099222128}, "reference-count": 49, "publisher": "Elsevier BV", "issue": "1-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 7, 1]], "date-time": "2001-07-01T00:00:00Z", "timestamp": 993945600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Controlled Release"], "published-print": {"date-parts": [[2001, 7]]}, "DOI": "10.1016/s0168-3659(01)00309-1", "type": "journal-article", "created": {"date-parts": [[2002, 10, 31]], "date-time": "2002-10-31T19:09:39Z", "timestamp": 1036091379000}, "page": "47-61", "source": "Crossref", "is-referenced-by-count": 600, "title": ["Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS"], "prefix": "10.1016", "volume": "74", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}, {"given": "Tomohiro", "family": "Sawa", "sequence": "additional", "affiliation": []}, {"given": "Toshimitsu", "family": "Konno", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Controlled Release"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0168365901003091?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0168365901003091?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 25]], "date-time": "2019-04-25T19:51:38Z", "timestamp": 1556221898000}, "score": 21.904238, "issued": {"date-parts": [[2001, 7]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2001, 7]]}, "issue": "1-3"}, "alternative-id": ["S0168365901003091"], "URL": "http://dx.doi.org/10.1016/s0168-3659(01)00309-1", "ISSN": ["0168-3659"], "issn-type": [{"value": "0168-3659", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:03:18Z", "timestamp": 1576778598907}, "reference-count": 82, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 1, 1]], "date-time": "2013-01-01T00:00:00Z", "timestamp": 1356998400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advanced Drug Delivery Reviews"], "published-print": {"date-parts": [[2013, 1]]}, "DOI": "10.1016/j.addr.2012.10.002", "type": "journal-article", "created": {"date-parts": [[2012, 10, 23]], "date-time": "2012-10-23T11:58:43Z", "timestamp": 1350993523000}, "page": "71-79", "source": "Crossref", "is-referenced-by-count": 1040, "title": ["The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo"], "prefix": "10.1016", "volume": "65", "author": [{"given": "Hiroshi", "family": "Maeda", "sequence": "first", "affiliation": []}, {"given": "Hideaki", "family": "Nakamura", "sequence": "additional", "affiliation": []}, {"given": "Jun", "family": "Fang", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Advanced Drug Delivery Reviews"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0169409X12003201?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0169409X12003201?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 20]], "date-time": "2018-11-20T00:24:36Z", "timestamp": 1542673476000}, "score": 21.904238, "issued": {"date-parts": [[2013, 1]]}, "references-count": 82, "journal-issue": {"published-print": {"date-parts": [[2013, 1]]}, "issue": "1"}, "alternative-id": ["S0169409X12003201"], "URL": "http://dx.doi.org/10.1016/j.addr.2012.10.002", "ISSN": ["0169-409X"], "issn-type": [{"value": "0169-409X", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}